Introduction
============

The discovery and production of (synthetic) antibiotics in the first half of the previous century has been one of medicine's greatest achievements. The use of antimicrobial agents has reduced morbidity and mortality of humans and contributed substantially to human's increased life span. Antibiotics are, either as therapeutic or as prophylactic agents, also widely used in agricultural practices.

The first discovered antimicrobial compound was penicillin (Flemming, [@B52]) a β-lactam antibiotic. Soon after this very important discovery, antibiotics were used to treat human infections starting with sulfonamide and followed by the aminoglycoside streptomycin and streptothricin (Domagk, [@B47]; Schatz and Waksman, [@B145]). Nowadays numerous different classes of antimicrobial agents are known and they are classified based on their mechanisms of action (Neu, [@B110]). Antibiotics can for instance inhibit protein synthesis, like aminoglycoside, chloramphenicol, macrolide, streptothricin, and tetracycline or interact with the synthesis of DNA and RNA, such as quinolone and rifampin. Other groups inhibit the synthesis of, or damage the bacterial cell wall as β-lactam and glycopeptide do or modify, like sulfonamide and trimethoprim, the energy metabolism of a microbial cell.

Upon the introduction of antibiotics it was assumed that the evolution of antibiotic resistance (AR) was unlikely. This was based on the assumption that the frequency of mutations generating resistant bacteria was negligible (Davies, [@B40]). Unfortunately, time has proven the opposite. Nobody initially anticipated that microbes would react to this assault of various chemical poisons by adapting themselves to the changed environment by developing resistance to antibiotics using such a wide variety of mechanisms. Moreover, their ability of interchanging genes, which is now well known as horizontal gene transfer (HGT) was especially unexpected. Later on it was discovered that the emergence of resistance actually began before the first antibiotic, penicillin, was characterized. The first β-lactamase was identified in *Escherichia coli* prior to the release of penicillin for use in medical practice (Abraham and Chain, [@B3]). Besides β-lactams, the aminoglycoside--aminocyclitol family was also one of the first groups of antibiotics to encounter the challenges of resistance (Wright, [@B179]; Bradford, [@B13]). Over the years it has been shown by numerous ecological studies that (increased) antibiotic consumption contributes to the emergence of AR in various bacterial genera (MARAN, [@B94], [@B95]; NethMap, [@B109]). Some examples of the link between antibiotic dosage and resistance development are the rise of methicillin-resistant *Staphylococcus aureus* (MRSA) and vancomycin-resistant enterococci (VRE). The initial appearance of MRSA was in 1960 (Jevons et al., [@B74]), whereas VRE were first isolated about 20 years ago (Uttley et al., [@B165]). Over the last decades they have remained a reason for concern, but additional public health threats in relation to resistant microorganisms have also arisen (see for example Cantón et al., [@B22]; Goossens, [@B58]; Allen et al., [@B6]).

Bacteria have become resistant to antimicrobials through a number of mechanisms (Spratt, [@B155]; McDermott et al., [@B101]; Magnet and Blanchard, [@B90]; Wright, [@B180]):

I.  Permeability changes in the bacterial cell wall which restricts antimicrobial access to target sites,

II. Active efflux of the antibiotic from the microbial cell,

III. Enzymatic modification of the antibiotic,

IV. Degradation of the antimicrobial agent,

V.  Acquisition of alternative metabolic pathways to those inhibited by the drug,

VI. Modification of antibiotic targets,

VII. Overproduction of the target enzyme.

These AR phenotypes can be achieved in microorganisms by chromosomal DNA mutations, which alter existing bacterial proteins, through transformation which can create mosaic proteins and/or as a result of transfer and acquisition of new genetic material between bacteria of the same or different species or genera (Spratt, [@B155]; Maiden, [@B92]; Ochman et al., [@B111]).

There are numerous examples of mutation based resistance. For example, macrolide resistance can be due to nucleotide(s) base substitutions in the 23S rRNA gene. However, a similar resistance phenotype may also result from mutations within the ribosomal proteins L4 and L22 (Vester and Douthwaite, [@B168]). Single nucleotide polymorphisms (SNPs) can be the cause for resistance against the synthetic drugs quinolones, sulfonamides, and trimethoprim (Huovinen et al., [@B68]; Hooper, [@B64]; Ruiz, [@B143]) and mutations within the *rpsL* gene, which encodes the ribosomal protein S12, can result in a high-level streptomycin resistance (Nair et al., [@B108]). A frame shift mutation in the chromosomal *ddl* gene, encoding a cytoplasm enzyme [d]{.smallcaps}-Ala--[d]{.smallcaps}-Ala ligase, can account for glycopeptides resistance (Casadewall and Courvalin, [@B26]).

Acquired Resistance
===================

This review deals with the description of acquired resistance against several classes of antibiotics. For each class the development of resistance is summarized along with the mechanisms of action. Furthermore an extensive summary is given of the resistance mechanisms and resistance genes involved.

Aminoglycoside
--------------

### History and action mechanism

The aminoglycoside antibiotics initially known as aminoglycosidic aminocyclitols are over 60 years old (Siegenthaler et al., [@B148]; Begg and Barclay, [@B11]). In the early 1940s the first aminoglycoside discovered was streptomycin in *Streptomyces griseus* (Schatz and Waksman, [@B145]). Several years later, additional aminoglycosides were characterized from other *Streptomyces* species; neomycin and kanamycin in 1949 and 1957, respectively. Furthermore, in the 1960s gentamicin was recovered from the actinomycete *Micromonospora purpurea*. Because most aminoglycosides have been isolated from either *Streptomyces* or *Micromonospora* a nomenclature system has been set up based on their source. Aminoglycosides that are derived from bacteria of the *Streptomyces* genus are named with the suffix "-mycin," while those which are derived from *Micromonospora* are named with the suffix "-micin."

The first semi-synthetic derivatives were isolated in the 1970s. For example netilmicin is a derivative of sisomicin whereas amikacin is derived from kanamycin (Begg and Barclay, [@B11]; Davies and Wright, [@B41]).

Aminoglycosides are antimicrobials since they inhibit protein synthesis and/or alter the integrity of bacterial cell membranes (Vakulenko and Mobashery, [@B166]). They have a broad antimicrobial spectrum. Furthermore, they often act in synergy with other antibiotics as such it makes them valuable as anti-infectants.

### Resistance mechanisms

Several aminoglycoside resistance mechanisms have been recognized; (I) Active efflux (Moore et al., [@B106]; Magnet et al., [@B91]), (II) Decreased permeability (Hancock, [@B62]; Taber et al., [@B162]), (III) Ribosome alteration (Poehlsgaard and Douthwaite, [@B123]), (IV) Inactivation of the drugs by aminoglycoside-modifying enzymes (Shaw et al., [@B147]). Intrinsic mechanisms, i.e., efflux pumps and 16S rRNA methylases but also chromosomal mutations can cause the first three resistance properties. In recent years acquired 16S rRNA methylases appear to have increased in importance (Galimand et al., [@B56]; Doi and Arakawa, [@B45]; Table [1](#T1){ref-type="table"}). The first gene identified of a plasmid-mediated type of aminoglycoside resistance was *armA* (Galimand et al., [@B55]). To date five additional methylases have been reported, i.e., *npmA*, *rmt*A, *rmtB*, *rmtC*, and *rmtD* (Courvalin, [@B37]; Doi et al., [@B46]). Data regarding the 16S rRNA methylase genes are accumulated and provided at the website: [www.nih.go.jp/niid/16s_database/index.html](www.nih.go.jp/niid/16s_database/index.html).

###### 

**Acquired Aminoglycoside resistance genes**.

  Gene name                                  Mechanism   Length (nt)   Accession number or reference   Coding region      Genera
  ------------------------------------------ ----------- ------------- ------------------------------- ------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *aac(2′)-Ia*                               ACT         537           L06156                          264..800           *Providencia*
  *aac(2′)-Ib*                               ACT         588           U41471                          265..852           *Mycobacterium*
  *aac(2′)-Ic*                               ACT         546           U72714                          373..918           *Mycobacterium*
  *aac(2′)-Id*                               ACT         633           U72743                          386..1018          *Mycobacterium*
  *aac(2′)-Ie*                               ACT         549           NC_011896                       3039059..3039607   *Mycobacterium*
  *aac(3)-I*                                 ACT         465           AJ877225                        5293..5757         *Pseudomonas*
  *aac(3)-Ia*                                ACT         534           X15852                          1250..1783         *Acinetobacter*, *Escherichia*, *Klebsiella*, *Salmonella*, *Serratia*, *Streptomyces*
  *aac(3)-Ib*                                ACT         531           L06157                          555..1085          *Pseudomonas*
  *aac(3)-Ib*-*aac(6′)-Ib*                   ACT         1,005         AF355189                        1435..2439         *Pseudomonas*
  *aac(3)-Ic*                                ACT         471           AJ511268                        1295..1765         *Pseudomonas*
  *aac(3)-Id*                                ACT         477           AB114632                        104..580           *Proteus*, *Pseudomonas*, *Salmonella*, *Vibrio*
  *aac(3)-Ie*                                ACT         477           AY463797                        8583..9059         *Proteus*, *Pseudomonas*, *Salmonella*, *Vibrio*
  *aac(3)-If*                                ACT         465           AY884051                        61..525            *Serratia*, *Pseudomonas*
  *aac(3)-Ig*                                ACT         477           CP000282                        2333620..2334096   *Saccharophagus*
  *aac(3)-Ih*                                ACT         459           CP000490                        509912..510370     *Paracoccus*
  *aac(3)-Ii*                                ACT         459           CP000356                        638262..638720     *Sphingopyxis*
  *aac(3)-Ij*                                ACT                       CP000155                                           *Hahella*
  *aac(3)-Ik*                                ACT         444           BX571856                        765853..766296     *Staphylococcus*
  *aac(3)-IIa*                               ACT         861           X51534                          91..951            *Acinetobacter*, *Enterobacter*, *Escherichia*, *Klebsiella*, *Pseudomonas*, *Salmonela*
  *aac(3)-IIb*                               ACT         810           M97172                          656..1465          *Serratia*
  *aac(3)-IIc*                               ACT         861           X54723                          819..1679          *Escherichia*
  *aac(3)-IId*                               ACT         861           EU022314                        1..861             *Escherichia*
  *aac(3)-IIe*                               ACT         861           EU022315                        1..861             *Escherichia*
  *aac(3)-IIIa*                              ACT         816           X55652                          1124..1939         *Pseudomonas*
  *aac(3)-IIIb*                              ACT         738           L06160                          984..1721          *Pseudomonas*
  *aac(3)-IIIc*                              ACT         840           L06161                          106..945           *Pseudomonas*
  *aac(3)-IVa*                               ACT         786           X01385                          244..1029          *Escherichia*
  *aac(3)-Va*                                                                                                             
  *aac(3)-Vb*                                                                                                             
  *aac(3)-VIa*                               ACT         900           M88012                          193..1092          *Enterobacter*, *Escherichia*, *Salmonella*
  *aac(3)-VIIa*                              ACT         867           M22999                          493..1359          *Streptomyces*
  *aac(3)-VIIIa*                             ACT         861           M55426                          466..1326          *Streptomyces*
  *aac(3)-IXa*                               ACT         846           M55427                          274..1119          *Micromonospora*
  *aac(3)-Xa*                                ACT         855           AB028210                        2711..3565         *Streptomyces*
  *aac(6′)*                                  ACT         441           AY553333                        1392..1832         *Pseudomonas*
  *aac*                                      ACT         555           AJ628983                        1985..2539         *Pseudomonas*
  *aac(6′)*                                  ACT         402           DQ302723                        81..482            *Pseudomonas*
  *aac(6′)*                                  ACT         555           EU912537                        2092..2646         *Pseudomonas*
  *aac(6′)-Ia*                               ACT         558           M18967                          757..1314          *Citrobacter*, *Escherichia*, *Klebsiella*, *Shigella*
  *aac(6′)-Ib*                               ACT         606           M21682                          380..985           *Klebsiella*, *Proteus*, *Pseudomonas*
  *aac(6′)-Ib-cr*                            ACT         519           EF636461                        1124..1642         *Enterobacter*, *Escherichia*, *Klebsiella*, *Pseudomonas*, *Salmonella*
  *aac(6′)-Ic*                               ACT         441           M94066                          1554..1994         *Serratia*
  *aac(6′)-Id*                               ACT         450           X12618                          905..1354          *Klebsiella*
  *aac(6′)-Ie*                                                                                                            
  *aac(6′)-If*                               ACT         435           X55353                          279..713           *Enterobacter*
  *aac(6′)-Ig*                               ACT         438           L09246                          544..981           *Acinetobacter*
  *aac(6′)-Ih*                               ACT         441           L29044                          352..792           *Acinetobacter*
  *aac(6′)-Ii*                               ACT         549           L12710                          169..717           *Enterococcus*
  *aac(6′)-Ij*                               ACT         441           L29045                          260..700           *Acinetobacter*
  *aac(6′)-Ik*                               ACT         438           L29510                          369..806           *Acinetobacter*
  *aac(6′)-Il*                               ACT         522           Z54241                          530..1051          *Acinetobacter*, *Citrobacter*
  *aac(6′)-Im*                               ACT         537           AF337947                        1215..1751         *Escherichia*
  *aac(6′)-In*                               ACT         573           Wu et al. ([@B182])                                *Citrobacter*
  *aac(6′)-Iq*                               ACT         552           AF047556                        127..678           *Klebsiella*, *Salmonella*
  *aac(6′)-Ir*                               ACT         441           AF031326                        1..441             *Acinetobacter*
  *aac(6′)-Is*                               ACT         441           AF031327                        1..441             *Acinetobacter*
  *aac(6′)-It*                               ACT         441           AF031328                        1..441             *Acinetobacter*
  *aac(6′)-Iu*                               ACT         441           AF031329                        1..441             *Acinetobacter*
  *aac(6′)-Iv*                               ACT         441           AF031330                        1..441             *Acinetobacter*
  *aac(6′)-Iw*                               ACT         441           AF031331                        1..441             *Acinetobacter*
  *aac(6′)-Ix*                               ACT         441           AF031332                        1..441             *Acinetobacter*
  *aac(6′)-Iy*                               ACT         438           AF144880                        3452..3979         *Salmonella*
  *aac(6′)-Iz*                               ACT         462           AF140221                        390..851           *Stenotrophomonas*
  *aac(6′)-Iaa*                              ACT         438           NC_003197                       1707358..1707795   *Salmonella*
  *aac(6′)-Iad*                              ACT         435           AB119105                        1..435             *Acinetobacter*
  *aac(6′)-Iae*                              ACT         552           AB104852                        1935..2486         *Pseudomonas*, *Salmonella*
  *aac(6′)-Iaf*                              ACT         552           AB462903                        1200..1751         *Pseudomonas*
  *aac(6′)-Iai*                              ACT         567           EU886977                        544..1110          *Pseudomonas*
  *aac(6′)-I30*                              ACT         555           AY289608                        1524..2078         *Salmonella*
  *aac(6′)-31*                               ACT         519           AJ640197                        2474..2992         *Acinetobacter*
  *aac(6′)-32*                               ACT         555           EF614235                        2247..2801         *Pseudomonas*
  *aac(6′)-33*                               ACT         555           GQ337064                        1203..1757         *Pseudomonas*
  *aac(6′)-IIa*                              ACT         555           M29695                          707..1261          *Aeromonas*, *Klebsiella*, *Pseudomonas*, *Salmonella*
  *aac(6′)-IIb*                              ACT         543           L06163                          532..1074          *Pseudomonas*
  *aac(6′)-IIc*                              ACT         582           AF162771                        62..643            *Enterobacter*, *Klebsiella*, *Pseudomonas*
  *aac(6′)-IId*                                                                                                           
  *aac(6′)-III*                                                                                                           
  *aac(6′)-IV*                               ACT         435           X55353                          279..713           *Enterobacter*
  *aac(6′)-aph(2″)*                          NUT         1,440         M13771                          304..1743          *Enterococcus*, *Lactobacillus*, *Staphylococcus*, *Streptococcus*
  *aacA29*                                   ACT         381           AY139599                        768..1148          Unknown
  *aacA43*                                   ACT         564           HQ247816                        639..1202          *Klebsiella*
  *aadA1*                                    NUT         972           X02340                          223..1194          *Acinetobacter, Aeromonas*, *Enterobacter*, *Escherichia*, *Klebsiella*, *Proteus*, *Pseudomonas*, *Salmonella*, *Shigella*, *Vibrio*
  *aadA1b*                                   NUT         792           M95287                          3320..4111         *Pseudomonas*, *Serratia*
  *aadA2*                                    NUT         780           X68227                          166..945           *Acinetobacter, Aeromonas*, *Citrobacter*, *Enterobacter*, *Escherichia*, *Klebsiella*, *Proteus*, *Pseudomonas*, *Salmonella*, *Shigella*, *Staphylococcus*, *Vibrio*, *Yersinia*
  *aadA3*                                    NUT         792           AF047479                        1296..2087         *Escherichia*
  *aadA4*                                    NUT         789           Z50802                          1306..2094         *Acinetobacter, Aeromonas*, *Escherichia*, *Pseudomonas*,
  *aadA5*                                    NUT         789           AF137361                        64..852            *Acinetobacter, Aeromonas*, *Escherichia*, *Pseudomonas*, *Salmonella*, *Shigella*, *Staphylococcus*, *Vibrio*
  *aadA6*                                    NUT         846           AF140629                        61..906            *Pseudomonas*
  *aadA7*                                    NUT         798           AF224733                        32..829            *Escherichia*, *Salmonella*, *Vibrio*
  *aadA8*                                    NUT         792           AF326210                        1..792             *Klebsiella*, *Vibrio*
  *aadA8b*                                   NUT         792           AM040708                        1174..1965         *Escherichia*
  *aadA9*                                    NUT         837           AJ420072                        26773..27609       *Corynebacterium*
  *aadA10*                                   NUT         834           U37105                          2807..3640         *Pseudomonas*
  *aadA11*                                   NUT         846           AY144590                        1..846             *Pseudomonas*, *Riemerella*
  *aadA12*                                   NUT         792           AY665771                        1..792             *Escherichia*, *Salmonella*, *Yersinia*
  *aadA13*                                   NUT         798           AY713504                        1..798             *Escherichia*, *Pseudomonas*, *Yersinia*
  *aadA14*                                   NUT         786           AJ884726                        540..1325          *Pasteurella*
  *aadA15*                                   NUT         792           DQ393783                        1800..2591         *Pseudomonas*
  *aadA16*                                   NUT         846           EU675686                        3197..4042         *Escherichia*, *Klebsiella*, *Vibrio*
  *aadA17*                                   NUT         792           FJ460181                        774..1565          *Aeromonas*
  *aadA21*                                   NUT         792           AY171244                        47..838            *Salmonella*
  *aadA22*                                   NUT         792           AM261837                        74..865            *Escherichia*, *Salmonella*
  *aadA23*                                   NUT         780           AJ809407                        119..898           *Salmonella*
  *aadA24*                                   NUT         780           AM711129                        1264..2043         *Escherichia*, *Salmonella*
  *aadC*                                     NUT         477           V01282                          225..701           *Staphylococcus*
  *aadD*                                     NUT         771           AF181950                        3176..3946         *Staphylococcus*
  *ant(2″)-Ia*                               NUT         543           X04555                          1296..1829         *Acinetobacter, Enterobacter*, *Escherichia*, *Klebsiella*, *Proteus*, *Pseudomonas*, *Salmonella*, *Serratia*, *Shigella*, *Vibrio*
  *ant(3″)-Ih-aac(6′)-IId*                   NUT-ACT     1,392         AF453998                        3555..4946         *Serratia*
  *ant(4′)-Ib*                               NUT         771           AJ506108                        209..979           *Bacillus*
  *ant(4′)-IIa*                              NUT         759           M98270                          145..903           *Pseudomonas*
  *ant(4′)-IIb*                              NUT         756           AY114142                        1061..1816         *Pseudomonas*
  *ant(6)-Ia*                                NUT         909           AF330699                        22..930            *Enterococcus*, *Staphylococcus*
  *ant(6)-Ib*                                NUT         858           FN594949                        27482..28339       *Campylobacter*
  *ant(9)-Ia*                                NUT         783           X02588                          331..1113          *Enterococcus*, *Staphylococcus*
  *ant(9)-Ib*                                NUT         768           M69221                          271..1038          *Enterococcus*, *Staphylococcus*
  *aph(2″)-Ia*                                                                                                            
  *aph(2″)-Ib*                               PHT         900           AF337947                        272..1171          *Enterococcus*, *Escherichia*
  *aph(2″)-Ic*                               PHT         921           U51479                          196..1116          *Enterococcus*
  *aph(2″)-Id*                               PHT         906           AF016483                        131..1036          *Enterococcus*
  *aph(2″)-Ie*                               PHT         906           AY743255                        131..1036          *Enterococcus*
  *aph(3′)-Ia*                               PHT         816           J01839                          1162..1977         *Escherichia*, *Klebsiella*, *Pseudomonas*, *Salmonella*
  *aph(3′)-Ib*                               PHT         816           M20305                          779..1594          *Escherichia*
  *aph(3′)-Ic*                               PHT         816           X625115                         410..1225          *Acinetobacter*, *Citrobacter*, *Escherichia*, *Klebsiella*, *Salmonella*, *Serratia*, *Yersinia*
  *aph(3′)-Id*                               PHT         816           Z48231                          820..1635          *Escherichia*
  *aph(3′)-IIa*                              PHT         795           X57709                          1..795             *Escherichia*, *Pseudomonas*, *Salmonella*
  *aph(3′)-IIb*                              PHT         807           X90856                          388..1194          *Pseudomonas*
  *aph(3′)-IIc*                              PHT         813           AM743169                        2377498..2378310   *Stenotrophomonas*
  *aph(3′)-III*                              PHT         795           M26832                          604..1398          *Bacillus*, *Campylobacter*, *Enterococcus*, *Staphylococcus*, *Streptococcus*
  *aph(3′)-IV*                               PHT         789           X03364                          277..1065          *Bacillus*
  *aph(3′)-Va*                               PHT         807           K00432                          307..1113          *Streptomyces*
  *aph(3′)-Vb*                               PHT         792           M22126                          373..1164          *Streptomyces*
  *aph(3′)-Vc*                               PHT         795           S81599                          282..1076          *Micromonospora*
  *aph(3′)-Va*                               PHT         780           X07753                          103..882           *Acinetobacter*, *Pseudomonas*
  *aph(3′)-VIb*                              PHT         780           AJ627643                        4934..5713         *Alcaligenes*
  *aph(3′)-VIIa*                             PHT         753           M29953                          131..1036          *Campylobacter*
  *aph(3′)-VIII*                             PHT         804           AF182845                        1..804             *Streptomyces*
  *aph(3′)-XV*                               PHT         795           Y18050                          4758..5552         *Achromobacter*, *Citrobacter*, *Pseudomonas*
  *aph(3^′′^)-Ia*                            PHT         819           M16482                          501..1319          *Streptomyces*
  *aph(3^′′^)-Ib*                            PHT         801           AB366441                        11310..12110       *Enterobacter*, *Escherichia*, *Klebsiella*, *Pasteurella*, *Pseudomonas*, *Salmonella*, *Shigella*, *Yersinia*, *Vibrio*
  *aph(4)-Ia*                                PHT         1,026         V01499                          231..1256          *Escherichia*
  *aph(4)-Ib*                                PHT         999           X03615                          232..1230          *Streptomyces*
  *aph(6)-Ia*                                PHT         924           AY971801                        1..924             *Streptomyces*
  *aph(6)-Ib*                                PHT         924           X05648                          382..1305          *Streptomyces*
  *aph(6)-Ic*                                PHT         801           X01702                          485..1285          *Escherichia*, *Pseudomonas*, *Salmonella*
  *aph(6)-Id*                                PHT         837           M28829                          866..1702          *Enterobacter*, *Escherichia*, *Klebsiella*, *Pasteurella*, *Pseudomonas*, *Salmonella*, *Shigella*, *Yersinia*, *Vibrio*
  *aph(7″)-Ia*                               PHT         999           X03615                          232..1230          *Streptomyces*
  *aph(9)-Ia*                                PHT         996           U94857                          151..1146          *Legionella*
  *aph(9)-Ib*                                PHT         993           U70376                          7526..8518         *Streptomyces*
  *apmA*                                     ACT         822           FN806789                        2858..3682         *Staphylococcus*
  *armA*                                     MET         774           AY220558                        1978..2751         *Acinetobacter, Citrobacter*, *Enterobacter*, *Escherichia*, *Klebsiella*, *Salmonella*, *Serratia*
  *npmA*                                     MET         660           AB261016                        3069..3728         *Escherichia*
  *rmtA*                                     MET         756           AB120321                        6677..7432         *Pseudomonas*
  *rmtB*                                     MET         756           AB103506                        1410..2165         *Enterobacter*, *Escherichia*, *Klebsiella*, *Pseudomonas*, *Serratia*
  *rmtC*                                     MET         846           AB194779                        6903..7748         *Proteus*, *Salmonella*
  *rmtD*                                     MET         744           DQ914960                        8889..9632         *Klebsiella*, *Pseudomonas*
  *rmtD2*                                    MET         744           HQ401565                        14139..14882       *Citrobacter*, *Enterobacter*
  *rmtE*                                     MET         822           GU201947                        55..876            *Escherichia*
  *spc*                                      MET         783           X02588                          331..1113          *Enterococcus*, *Staphylococcus*
  *sph*                                      NUT         801           X64335                          6557..7354         *Escherichia*, *Pseudomonas*, *Salmonella*
  *str*                                      NUT         849           X92946                          18060..18908       *Enterococcus*, *Staphylococcus, Lactococcus*
  *sat2*[^A^](#t1fn1){ref-type="table-fn"}   ACT         525           X51546                          518..1042          *Acinetobacter, Enterobacter*, *Escherichia*, *Klebsiella*, *Proteus*, *Pseudomonas*, *Salmonella*, *Shigella*, *Vibrio*
  *sat3*[^A^](#t1fn1){ref-type="table-fn"}   ACT         543           Z48231                          221..763           *Escherichia*
  *sat4*[^A^](#t1fn1){ref-type="table-fn"}   ACT         543           X92945                          38870..39412       *Campylobacter*, *Enterococcus*, *Staphylococcus*, *Streptococcus*

*This table was adapted from: Elbourne and Hall ([@B50]), Magnet and Blanchard ([@B90]), Partridge et al. ([@B118]), Ramirez and Tolmansky ([@B128]), Shaw et al. ([@B147]), Vakulenko and Mobashery ([@B166]), and data provided by B. Guerra, B. Aranda, D. Avsaroglu, B. Ruiz del Castillo, and R. Helmuth, on behalf of the Med-Vet Net (EU Network of Excellence) WP29 Project Group. The data were collected within the subproject "AME's," with following participants representing their Institutions: Agnes Perry Guyomard (ANSES), Dik Mevius (CVI), Yvonne Agerso (DTU), Katie Hopkins (HPA), Silvia Herrera (ISCIII), Alessandra Carattoli (ISS), Antonio Battisti (IZS-Rome), Stefano Lollai (IZS-Sardegna), Lotte Jacobsen (SSI), Béla Nagy (VMRI), M. Rosario Rodicio and M. C. Mendoza (University of Oviedo, UO), Luis Martínez-Martínez (University Hospital of Valdecilla, HUV), and Bruno Gonzalez-Zorn (UCM)*.

*ACT, Acetyltransferase; MET, Methyltransferase; NUT, Nucleotidyltransferase; PHT, Phosphotransferase*.

^A^*Although the *sat* genes are not aminoglycoside resistance determinants, they encode streptothricin acetyltransferases, for convenience they are included in this table*.

The major encountered aminoglycoside resistance mechanism is the modification of enzymes. These proteins are classified into three major classes according to the type of modification: AAC (acetyltransferases), ANT (nucleotidyltransferases or adenyltransferases), APH (phosphotransferases; Shaw et al., [@B147]; Wright and Thompson, [@B181]; Magnet and Blanchard, [@B90]; Wright, [@B180]; Ramirez and Tolmansky, [@B128]). Within these classes, an additional subdivision can be made based on the enzymes different region specificities for aminoglycoside modifications: i.e., there are four acetyltransferases: AAC(1), AAC(2′), AAC(3), and AAC(6′); five nucleotidyltransferases: ANT(2″), ANT(3″), ANT(4′), ANT(6), and ANT(9) and seven phosphotransferases: APH(2″), APH(3′), APH(3″), APH(4), APH(6), APH(7″), and APH(9). Furthermore, there also exists a bifunctional enzyme, AAC(6′)--APH(2″), that can acetylate and phosphorylate its substrates sequentially (Shaw et al., [@B147]; Kotra et al., [@B82]). Table [1](#T1){ref-type="table"} displays the currently known aminoglycoside resistance genes. The action mechanisms of the determinants, the variety in gene lengths, accession numbers, and the distribution are all indicated. As can be deduced from the second column of Table [1](#T1){ref-type="table"}, inconsistencies arose in the nomenclature of genes for aminoglycoside-modifying enzymes (Vakulenko and Mobashery, [@B166]). In some cases, genes were named according to the site of modification, followed by a number to distinguish between genes. Using a different nomenclature, for example, the genes for AAC(6′)-Ia and AAC(3)-Ia are referred to as *aacA1* and *aacC1*, respectively. The nomenclature proposed by Shaw et al. ([@B147]), who utilize the identical names for the enzymes and the corresponding genes, but the names of genes are in lowercase letters and italicized will be used in this review (see Table [1](#T1){ref-type="table"}). According to this more convenient nomenclature, the genes for the AAC(6′)-Ia and AAC(3)-Ia enzymes are termed *aac(6*′*)-Ia* and *aac(3)-Ia*, respectively.

β-Lactam
--------

### History and action mechanism

As already mentioned before, the first antibiotic discovered was a β-lactam, i.e., penicillin. The Scottish scientist Alexander Flemming accidentally noticed the production of a substance with antimicrobial properties by the mold *Penicillium notatum* (Flemming, [@B52]). Over the last 30 years, many new β-lactam antibiotics have been developed. By definition, all β-lactam antibiotics have a β-lactam nucleus in their molecular structure. The β-lactam antibiotic family includes penicillins and derivatives, cephalosporins, carbapenems, monobactams, and β-lactam inhibitors (Williams, [@B175]; Bush, [@B18]; Petri, [@B122]; Queenan and Bush, [@B126]).

The core compound of penicillin, 6-aminopenicillanic acid (6-APA) is used as the main starting point for the preparation of numerous semi-synthetic derivatives. Although the cephalosporins are often thought of as new and improved derivatives of penicillin, they were actually discovered as naturally occurring substances (Petri, [@B122]). They can be grouped in first, second, third, and forth generation cephalosporins according to their spectrum of activity and timing of the agent's introduction. In general, first generation agents have good Gram-positive activity and relatively modest coverage for Gram-negative organisms; second generation cephalosporins have increased Gram-negative and somewhat less Gram-positive activity; third generation antimicrobials have improved Gram-negative and variable Gram-positive activity; forth generation β-lactams have good true broad spectrum activity against both Gram-negatives and Gram-positives (Williams, [@B175]; Marshall et al., [@B96]). The second generation cephamycins are sometimes also grouped among the cephalosporins.

Because carbapenems diffuse easily in bacteria they are considered as broad spectrum β-lactam antibiotic. Imipenem and meropenem are well known representative. Even though monobactams do not contain a nucleus with a fused ring attached, they still belong to the β-lactam antibiotics. The β-lactamase inhibitors, like clavulanic acid, do contain the β-lactam ring, but they exhibit negligible antimicrobial activity and are used in combination with β-lactam antibiotics to overcome resistance in bacteria that secrete β-lactamase, which otherwise inactivates most penicillins.

The β-lactam antibiotics work by inhibiting the cell wall synthesis by binding to so-called penicillin-binding proteins (PBPs) in bacteria and interfering with the structural cross linking of peptidoglycans and as such preventing terminal transpeptidation in the bacterial cell wall. As a consequence it weakens the cell wall of the bacterium and finally results in cytolysis or death due to osmotic pressure (Kotra and Mobashery, [@B83]; Andes and Craig, [@B9]).

The β-lactamase inhibitors can be classified as either reversible or irreversible and the latter are considered more effective in that they eventually result in the destruction of enzymatic activity. Not surprisingly the inhibitors in clinical use, i.e., clavulanic acid, sulbactam, and tazobactam are all examples of irreversible β-lactamase inhibitors (Bush, [@B17]; Drawz and Bonomo, [@B48]).

### Resistance mechanisms

The first bacterial enzyme reported to destroy penicillin was an AmpC β-lactamase of *E. coli* (Abraham and Chain, [@B3]). Nowadays, bacterial resistance against β-lactam antibiotics is increasing at a significant rate and has become a common problem. There are several mechanisms of antimicrobial resistance to β-lactam antibiotics. The most common and important mechanism through which bacteria can become resistant against β-lactams is by expressing β-lactamases, for example extended-spectrum β-lactamases (ESBLs), plasmid-mediated AmpC enzymes, and carbapenem-hydrolyzing β-lactamases (carbapenemases; Bradford, [@B13]; Jacoby and Munoz-Price, [@B73]; Paterson and Bonomo, [@B119]; Poirel et al., [@B125]; Queenan and Bush, [@B126]; Jacoby, [@B72]).

The β-lactamase family has been subdivided either based on functionality or molecular characteristics. Initially, before genes were routinely sequenced various biochemical parameters were determined of the different β-lactamases which allowed classification of this AR determinants family into four groups (Bush et al., [@B20]; Wright, [@B180]). Groups 1, 2, and 4 are serine-β-lactamases, while members of group 3 are metallo-β-lactamases. Classification based on molecular characteristics, i.e., amino acid homology has also resulted in four major groups, the so-called Ambler classes A--D, which correlate well with the functional scheme but lack details concerning the enzymatic activity. Ambler classes A, C, and D include the β-lactamases with serine at their active site, whereas Ambler class B β-lactamases are all metallo-enzymes who require zinc as a metal cofactor for their catalytic activities (Ambler, [@B7]; Bradford, [@B13]; Paterson and Bonomo, [@B119]; Wright, [@B180]; Poirel et al., [@B125], [@B124]; Bush and Jacoby, [@B19]; Drawz and Bonomo, [@B48]). In this review the Ambler classification will be used (Table [2](#T2){ref-type="table"}).

###### 

**β-Lactamases and ESBLs families**.

  Amber class A β-lactamases and ESBLs   Number of variants\*   Amber class B β-lactamases and MBLs   Number of variants\*   Amber class C β-lactamases and ESBLs   Number of variants\*   Amber class D β-lactamases and ESBLs   Number of variants\*
  -------------------------------------- ---------------------- ------------------------------------- ---------------------- -------------------------------------- ---------------------- -------------------------------------- ----------------------
  *bla*~ACI~                             1                      *bla*~B~                              13                     *bla*~ACC~^a^                          4                      *ampH*                                 1
  *bla*~AER~                             1                      *bla*~CGB~                            2                      *bla*~ACT~^a^                          9                      *ampS*                                 1
  *bla*~AST~                             1                      *bla*~DIM~                            1                      *bla*~BIL~                             1                      *bla*~LCR~                             1
  *bla*~BEL~                             3                      *bla*~EBR~                            1                      *bla*~BUT~                             2                      *bla*~NPS~                             1
  *bla*~BES~                             1                      *bla*~GIM~                            1                      *bla*~CFE~^a^                          1                      *bla*~OXA~^a^                          219
  *bla*~BIC~                             1                      *bla*~GOB~                            18                     *bla*~CMG~                             1                      *loxA*                                 1
  *bla*~BPS~                             5                      *bla*~IMP~^a^                         30                     *bla*~CMY~^a^                          72                                                            
  *bla*~CARB~                            8                      *bla*~IND~^a^                         7                      *bla*~DHA~^a^                          8                                                             
  *bla*~CKO~                             5                      *bla*~JOHN~                           1                      *bla*~FOX~^a^                          10                                                            
  *bla*~CME~                             2                      *bla*~MUS~                            1                      *bla*~LAT~^a^                          1                                                             
  *bla*~CTX-M~^a^                        119                    *bla*~NDM~                            6                      *bla*~LEN~^c^                          24                                                            
  *bla*~DES~                             1                      *bla*~SPM~                            1                      *bla*~MIR~^a^                          5                                                             
  *bla*~ERP~                             1                      *bla*~TUS~                            1                      *bla*~MOR~                             1                                                             
  *bla*~FAR~                             2                      *bla*~VIM~^a^                         30                     *bla*~MOX~^a^                          8                                                             
  *bla*~FONA~                            6                      *cepA*                                7                      *bla*~OCH~                             7                                                             
  *bla*~GES~^a,b^                        17                     *cfiA*                                16                     *bla*~OKP-A~^c^                        16                                                            
  *bla*~HERA~                            8                      *cphA*                                8                      *bla*~OKP-B~^c^                        20                                                            
  *bla*~IMI~                             3                      *imiH*                                1                      *bla*~OXY~^c^                          23                                                            
  *bla*~KLUA~^d^                         12                     *imiS*                                1                      *bla*~TRU~                             1                                                             
  *bla*~KLUC~^d^                         2                                                                                   *bla*~ZEG~                             1                                                             
  *bla*~KLUG~                            1                                                                                   *cepH*                                 1                                                             
  *bla*~KLUY~                            4                                                                                                                                                                                        
  *bla*~KPC~^a^                          11                                                                                                                                                                                       
  *bla*~LUT~                             6                                                                                                                                                                                        
  *bla*~MAL~                             2                                                                                                                                                                                        
  *bla*~MOR~                             1                                                                                                                                                                                        
  *bla*~NMC-A~                           1                                                                                                                                                                                        
  *bla*~PER~^a^                          7                                                                                                                                                                                        
  *bla*~PME~                             1                                                                                                                                                                                        
  *bla*~PSE~                             4                                                                                                                                                                                        
  *bla*~RAHN~                            2                                                                                                                                                                                        
  *bla*~ROB~                             1                                                                                                                                                                                        
  *bla*~SED~                             1                                                                                                                                                                                        
  *bla*~SFC~                             1                                                                                                                                                                                        
  *bla*~SFO~                             1                                                                                                                                                                                        
  *bla*~SHV~^a^                          141                                                                                                                                                                                      
  *bla*~SME~^a^                          3                                                                                                                                                                                        
  *bla*~TEM~^a^                          187                                                                                                                                                                                      
  *bla*~TLA~                             1                                                                                                                                                                                        
  *bla*~TOHO~                            1                                                                                                                                                                                        
  *bla*~VEB~^a^                          7                                                                                                                                                                                        
  *bla*~Z~                               1                                                                                                                                                                                        
  *cdiA*                                 1                                                                                                                                                                                        
  *cfxA*                                 6                                                                                                                                                                                        
  *cumA*                                 1                                                                                                                                                                                        
  *hugA*                                 1                                                                                                                                                                                        
  *penA*                                 1                                                                                                                                                                                        

*\*Last update: June 17th, 2011*.

*^a^According to <http://www.lahey.org/Studies>*.

*^b^GES and IBC-type ESBLs have all been renamed as *bla*~GES~ according to Weldhagen et al. ([@B173])*.

*^c^According to <http://www.pasteur.fr/ip/easysite/go/03b-00002u-03q/beta-lactamase-enzyme-variants>*.

*^d^*bla*~KLUA~, *bla*~KLUC~, *bla*~KLUG~, and *bla*~KLUY~ seem to be the chromosomal progenitors of acquired CTX-M group 2, 1, 8, and 9 genes, respectively (Saladin et al., [@B144]; Olson et al., [@B113])*.

In addition to the production of β-lactamases resistance can also be due to possession of altered PBPs. Since β-lactams cannot bind as effectively to these altered PBPs, the antibiotic is less effective at disrupting cell wall synthesis. The PBPs are thought to be the ancestors of the naturally occurring chromosomally mediated β-lactamase in many bacterial genera (Bradford, [@B13]).

Although plasmid-encoded penicillinase arose much earlier in Gram-positives in *Staphylococcus aureus*, due to the use of penicillin (Aarestrup and Jensen, [@B2]), the first plasmid-mediated β-lactamase, TEM-1, was described in the early 1960s in Gram-negatives (Datta and Kontomichalou, [@B39]). Currently over 1,150 chromosomal, plasmid, and transposon located β-lactamases are currently known (Bush and Jacoby, [@B19]; Drawz and Bonomo, [@B48]; Table [2](#T2){ref-type="table"}).

Based on their activity to hydrolyze a small number or a variety of β-lactams the enzymes can be subdivided into narrow-, moderate-, broad-, and ESBLs. A commonly used definition specifies that broad spectrum β-lactamases are capable to provide resistance to the penicillins and cephalosporins and are not inhibited by inhibitors such as clavulanic acid and tazobactam. The ESBLs confer resistance to the penicillins, first-, second-, and third-generation cephalosporins and aztreonam, but not to carbapenems and are inhibited by β-lactamase inhibitors. In recent years acquired AR genes encoding ESBLs have become a major concern (Bradford, [@B13]). In time the parent enzymes *bla*~TEM-1~, *bla*~TEM-2~, and *bla*~SHV-1~ have undergone amino acid substitutions (point mutations) evolving to the ESBLs, starting with *bla*~TEM-3~ and *bla*~SHV-2~ (Bradford, [@B13]). Additional mutations at critical amino acids important for catalysis resulted in over 140 currently known SHV and TEM ESBL variants. In addition, plasmid-encoded class C β-lactamases or AmpC determinants, like *bla*~CMY~ have also caught people's awareness (Jacoby, [@B72]). Furthermore, in the past decade CTX-M enzymes have become very prevalent ESBLs, both in nosocomial and in community settings (Cantón and Coque, [@B21]).

Table [2](#T2){ref-type="table"} illustrates the size and diversity of the group of β-lactamases and ESBLs. The vast and still increasing number of (broad spectrum) β-lactamases and ESBLs has become a problem for the nomenclature for novel genes. Names have been assigned according to individual preference rather than according to systematic procedures (Bush, [@B18]). Fortunately, an authoritative website has been constructed on the nomenclature of ESBLs hosted by Jacoby and Bush[^1^](#fn1){ref-type="fn"}.

Chloramphenicol
---------------

### History and action mechanism

In 1947, the first chloramphenicol, originally referred to as chloromycetin, was isolated from *Streptomyces venezuelae* (Ehrlich et al., [@B49]). Probably because chloramphenicol is a molecule with a rather simple structure only a small number of synthetic derivates have been synthesized without adverse effects on antimicrobial activity (Schwarz et al., [@B146]). In azidamfenicol two chlorine atoms (−Cl~2~) are replaced by an azide group. Substitution of the nitro group (−NO~2~), by a methyl--sulfonyl residue (−SO~2~CH~3~) resulted in the synthesis of thiamphenicol, whereas in the fluorinated thiamphenicol derivative florfenicol the hydroxyl group (−OH) is replaced with fluorine (−F).

Chloramphenicol is a highly specific and potent inhibitor of protein synthesis through its affinity for the peptidyltransferase of the 50S ribosomal subunit of 70S ribosomes (Schwarz et al., [@B146]). Due to its binding to this enzyme the antibiotic prevents peptide chain elongation. The substrate spectrum of chloramphenicol includes Gram-positive and Gram-negative, aerobic and anaerobic bacteria. Chloramphenicol analogs including the fluorinated derivative florfenicol have a similar spectrum of activity.

### Resistance mechanism

The first and still most frequently encountered mechanism of bacterial resistance to chloramphenicol is enzymatic inactivation by acetylation of the drug via different types of chloramphenicol acetyltransferases (CATs; Murray and Shaw, [@B107]; Schwarz et al., [@B146]; Wright, [@B180]). CATs are able to inactivate chloramphenicol as well as thiamphenicol and azidamfenicol, however, due to its structural modification florfenicol is resistant to inactivation by these enzymes. Consequently, chloramphenicol resistant strains, in which resistance is exclusively based on the activity of CAT, are susceptible to florfenicol. There are two defined types of genes coding CATs which distinctly differ in their structure: i.e., the classical *catA* determinants and the novel, also known as xenobiotic CATs, encoded by *catB* variants (Table [3](#T3){ref-type="table"}). Besides the inactivating enzymes, there are also reports on other chloramphenicol resistance systems, such as inactivation by phosphotransferases, mutations of the target site, permeability barriers, and efflux systems (Schwarz et al., [@B146]). Of the latter mechanism, *cmlA* and *floR* are the most commonly known (Bissonnette et al., [@B12]; Briggs and Fratamico, [@B14]). The presence of a *cmlA* gene will result in resistance to chloramphenicol, but susceptibility to florfenicol. In contrast, *floR* will give rise to a chloramphenicol and florfenicol resistance phenotype. Inconsistencies in the nomenclature arose, like with many other AR genes, due to the increasing number of chloramphenicol resistance determinants. Schwarz et al. ([@B146]) suggested a unified nomenclature. Table [3](#T3){ref-type="table"} represents the currently known chloramphenicol/florfenicol resistance genes. Some characteristics which are mentioned in Table [3](#T3){ref-type="table"} are mechanism of action, diverse gene lengths, accession numbers, and the distribution.

###### 

**Acquired chloramphenicol resistance genes**.

  Group       Gene           Gene(s) included                                                 Mechanism             Length (nt)   Accession number   Coding region      Genera
  ----------- -------------- ---------------------------------------------------------------- --------------------- ------------- ------------------ ------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Type A-1    *catA1*        *cat*, *catI*, *pp-cat*                                          Inactivating enzyme   660           V00622             244..903           *Acinetobacter*, *Escherichia*, *Klebsiella*, *Salmonella*, *Serratia*, *Shigella*
  Type A-2    *catA2*        *cat*, *catII*                                                   Inactivating enzyme   642           X53796             187..828           *Aeromonas, Agrobacterium*, *Escherichia*, *Haemophilus*, *Photobacterium*, *Salmonella*
  Type A-3    *catA3*        *cat*, *catIII*                                                  Inactivating enzyme   642           X07848             272..913           *Actinobacillus*, *Edwardsiella*, *Klebsiella*, *Mannheimia*, *Pasteurella*, *Shigella*
  Type A-4    *Cat*                                                                           Inactivating enzyme   654           M11587             880..1533          *Proteus*
  Type A-5    *Cat*                                                                           Inactivating enzyme   663           P20074\*           1002758..1003420   *Streptomyces*
  Type A-6    *cat86*                                                                         Inactivating enzyme   663           K00544             145..807           *Bacillus*
  Type A-7    *cat(pC221)*   *cat*, *catC*                                                    Inactivating enzyme   648           X02529             2267..2914         *Bacillus*, *Enterococcus*, *Lactobacillus*, *Staphylococcus*, *Streptococcus*
  Type A-8    *cat(pC223)*   *cat*                                                            Inactivating enzyme   648           AY355285           1000..1647         *Enterococcus*, *Lactococcus*, *Listeria*, *Staphylococcus*, *Streptococcus*
  Type A-9    *cat(pC194)*   *cat*, *cat-TC*                                                  Inactivating enzyme   651           NC_002013          1260..1910         *Bacillus*, *Enterococcus*, *Lactobacillus*, *Staphylococcus*, *Streptococcus*
  Type A-10   *Cat*                                                                           Inactivating enzyme   687           AY238971           1055..1741         *Bacillus*
  Type A-11   *catP*         *catD*                                                           Inactivating enzyme   624           U15027             2953..3576         *Clostridium*, *Neisseria*
  Type A-12   *catS*                                                                          Inactivating enzyme   492^§^        X74948             1..492             *Streptococcus*
  Type A-13   *Cat*                                                                           Inactivating enzyme   624           M35190             309..932           *Aeromonas*, *Campylobacter*
  Type A-14   *Cat*                                                                           Inactivating enzyme   651           S48276             479..1129          *Listonella*, *Photobacterium*, *Proteus*
  Type A-15   *catB*                                                                          Inactivating enzyme   660           M93113             145..804           *Clostridium*
  Type A-16   *catQ*                                                                          Inactivating enzyme   660           M55620             459..1118          *Clostridium*, *Streptococcus*
  Type B-1    *catB1*        *cat*                                                            Inactivating enzyme   630           M58472             148..777           *Agrobacterium*
  Type B-2    *catB2*                                                                         Inactivating enzyme   633           AF047479           5957..6589         *Acinetobacter*, *Aeromonas*, *Bordetella*, *Escherichia*, *Klebsiella*, *Pasteurella*, *Pseudomonas*, *Salmonella*
  Type B-3    *catB3*        *catB4*, *catB5*, *catB6*, *catB8*                               Inactivating enzyme   633           AJ009818           883..1515          *Acinetobacter*, *Aeromonas*, *Bordetella*, *Enterobacter*, *Escherichia*, *Klebsiella*, *Kluyvera*, *Morganella*, *Pseudomonas*, *Salmonella*, *Serratia*, *Shigella*
  Type B-4    *catB7*                                                                         Inactivating enzyme   639           AF036933           177..815           *Pseudomonas*
  Type B-5    *catB9*                                                                         Inactivating enzyme   630           AF462019           27..656            *Vibrio*
  Type B-6    *catB10*                                                                        Inactivating enzyme   633           AF878850           1197..1829         *Pseudomonas*
  Type E-1    *cmlA1*        *cmlA, cmlA2, cmlA4, cmlA5, cmlA6, cmlA7, cmlA8, cmlA10, cmlB*   Efflux                1,260         M64556             601..1860          *Acinetobacter*, *Aeromonas*, *Arcanobacterium*, *Enterobacter*, *Escherichia*, *Klebsiella*, *Pseudomonas*, *Salmonella*, *Serratia*, *Staphylococcus*
  Type E-2    *cml*                                                                           Efflux                903           M22614             427..1335          *Escherichia*
  Type E-3    *floR*         *cmlA*-like, *flo*, *pp-flo, cmlA9*                              Efflux                1,215         AF071555           4445..5659         *Acinetobacter*, *Aeromonas*, *Bordetella*, *Pasteurella*, *Salmonella*, *Stenotrophomonas*, *Vibrio*
  Type E-4    *fexA*                                                                          Efflux                1,428         AJ549214           177..1604          *Bacillus*, *Staphylococcus*
  Type E-5    *cml*                                                                           Efflux                1,179         X59968             508..1686          *Corynebacterium*, *Pseudomonas*
  Type E-6    *cmlv*                                                                          Efflux                1,311         U09991             28..1338           *Staphylococcus*
  Type E-7    *cmrA*         *cmr*                                                            Efflux                1,176         Z12001             993..2168          Uncultured
  Type E-8    *cmr*          *cmx*                                                            Efflux                1,176         U85507             3518..4693         *Acinetobacter*, *Escherichia*, *Klebsiella*, *Salmonella*, *Serratia*, *Shigella*
              *cfr*                                                                           Inactivating enzyme   1,050         AJ579365           6290..7339         *Aeromonas, Agrobacterium*, *Escherichia*, *Haemophilus*, *Photobacterium*, *Salmonella*
              *pexA*                                                                          Efflux                1,248         HM537013           24055..25302       *Actinobacillus*, *Edwardsiella*, *Klebsiella*, *Mannheimia*, *Pasteurella*, *Shigella*

*Adapted from Partridge et al. ([@B118]), Schwarz et al. ([@B146]). **^§^**Partial sequence. **\***Protein accession number, nucleotide sequence not available in DNA library*.

Glycopeptide
------------

### History and action mechanism

In the late 1950s, the first glycopeptide, vancomycin was introduced in a clinical setting. Vancomycin was isolated as a fermentation product from a soil bacterium, *Streptomyces orientalis*, displaying antimicrobial activity (McCormick et al., [@B100]). Nearly 30 years later followed another glycopeptide antibiotic, teicoplanin (Parenti et al., [@B115]). Currently, four groups of glycopeptides are recognized, i.e., vancomycin type, avoparcin type, ristocetin type, and teicoplanin type. (Yao and Crandall, [@B184]). Among them, vancomycin and teicoplanin are the only two therapeutics currently used against Gram-positive microorganisms. During the 1990s, an association between the use of avoparcin and the occurrence of glycopeptide-resistant enterococci (GRE), more commonly designated VRE, in farm animals was demonstrated (Aarestrup, [@B1]; Klare et al., [@B80]). As a consequence avoparcin was banned as a growth promoter in all European Union countries in 1997.

Glycopeptides have an unusual mode of action. Instead of inhibiting an enzyme, they bind to a substrate. To be more specific, the molecular target of these glycopeptide antibiotics is the [d]{.smallcaps}-alanyl--[d]{.smallcaps}-alanine ([d]{.smallcaps}-Ala--[d]{.smallcaps}-Ala) terminus of the cell wall peptidoglycan precursor. After the glycopeptides are bound to their target, they inhibit the subsequent transglycosylation reaction by steric hindrance. (Gao, [@B57]; Klare et al., [@B81]).

### Resistance mechanism

The introduction of antibiotics into clinical setting is usually followed by the fairly rapid emergence of resistant bacteria. In this respect, vancomycin was somewhat atypical, because for almost 30 years following its introduction, resistance to this glycopeptide was reported only rarely and appeared to have little clinical significance. However, in the late 1980s, the emergence of acquired glycopeptides resistance was recognized for the first time (Leclercq et al., [@B85]; Johnson et al., [@B75]). This vancomycin resistance resulted from the production of modified peptidoglycan precursors ending in [d]{.smallcaps}-Ala--[d]{.smallcaps}-Lac (VanA, VanB, and VanD) or [d]{.smallcaps}-Ala--[d]{.smallcaps}-Ser (VanC, VanE, and VanG), to which glycopeptides exhibit low binding affinities. Classification of glycopeptide resistance is based on the primary sequence of the structural genes for the resistance-mediating ligases. The *van*A and *vanB* operons are located on plasmids or on the chromosome, whereas the *vanC1*, *vanC2/3*, *vanD*, *vanE*, and *vanG* have so far been found exclusively on the chromosome (Gao, [@B57]; Klare et al., [@B81]; Depardieu et al., [@B43]). Currently, resistance to the glycopeptides, vancomycin, and teicoplanin or both, has been detected in six, all Gram-positive bacterial genera: *Enterococcus*, *Erysipelothrix*, *Lactobacillus*, *Leuconostoc*, *Pediococcus*, and *Staphylococcus* (Woodford et al., [@B177]).

Macrolide--Lincosamide--Streptogramin B
---------------------------------------

### History and action mechanism

The first macrolide, erythromycin A, was discovered in the early 1950s (McGuire et al., [@B102]). The main structural component of this molecule is a large lactone ring to which amino and/or neutral sugars are attached by glycosidic bonds. To address the limitations of erythromycin, like chemical instability, poor absorbance, and bitter taste, newer 14-, 15-, and 16-membered ring macrolides such as clarithromycin and the azalide, azithromycin, have been developed (Kirst, [@B79]; Roberts, [@B136]).

Macrolides have a similar mode of antibacterial action and comparable antibacterial spectra as two other antibiotic classes, i.e., lincosamides and streptogramins B. Consequently, these antibiotics, although chemically distinct, have been clustered together as Macrolide--Lincosamide--Streptogramin B (MLS) antibiotics (Roberts, [@B136]). Nowadays this class of antibiotics should even be extended due to the development of various synthetic drugs. The ketolides (Zhanel et al., [@B185]; Ackermann and Rodloff, [@B4]) and oxazolidinones (Diekema and Jones, [@B44]) can be grouped together with the MLS antimicrobial agents which results in the MLSKO family of antibiotics (Roberts, [@B138]).

Macrolides, lincosamides, and streptogramins B all inhibit protein synthesis by binding to the 50S ribosomal subunit of bacteria (Weisblum, [@B172]; Roberts, [@B136]).

### Resistance mechanism

Shortly after the introduction of erythromycin into clinical setting in the 1950s, bacterial resistance to this antibiotic was reported for the first time in staphylococci (Weisblum, [@B172]). Since then a large number of bacteria have been identified that are resistant to MLS due to the presence of various different genes. The AR determinants responsible include rRNA methylases, efflux, and inactivating genes (Roberts et al., [@B139]; Roberts, [@B138]). The latter group can be further subdivided in esterases, lyases, phosphorylases, and transferases (Table [4](#T4){ref-type="table"}).

###### 

**Acquired macrolide--lincosamide--streptogramin B (MLS) resistance genes**.

  Gene           Gene(s) included                                                                        Mechanism                Length (nt)   Accession number             Coding region   Genera
  -------------- --------------------------------------------------------------------------------------- ------------------------ ------------- ---------------------------- --------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *car*(A)                                                                                               Efflux                   1,656         M80346                       411..2066       *Streptomyces*
  *cfr*                                                                                                  rRNA methylase           1,050         AM408573                     10028..11077    S*taphylococcus*
  *cmr*                                                                                                  Other                    1,380         U43535                       646..2025       *Corynebacterium*
  *ere*(A)                                                                                               Inactivating enzyme^A^   1,221         AY183453                     2730..3950      *Citrobacter*, *Enterobacter*, *Escherichia*, *Klebsiella*, *Pantoea*, *Providencia*, *Pseudomonas*, *Serratia*, *Staphylococcus*, *Stenotrophomonas*, *Vibrio*
  *ere*(B)                                                                                               Inactivating enzyme^A^   1,260         X03988                       383..1642       *Acinetobacter*, *Citrobacter*, *Enterobacter*, *Escherichia*, *Klebsiella*, *Proteus*, *Pseudomonas*, S*taphylococcus*
  *ere*(C)                                                                                               Inactivating enzyme^A^   1,257         FN396877                     943..2199       *Klebsiella*
  *erm*(A)       *erm*(TR)                                                                               rRNA methylase           732           X03216                       4551..5282      *Aggregatibacter*, *Bacteroides*, *Enterococcus*, *Helcococcus*, *Peptostreptococcus*, *Prevotella*, *Staphylococcus*, *Streptococcus*
  *erm*(B)       *erm*(2), *erm*(AM), *erm*(AMR), *erm*(BC), *erm*(BP), *erm*(BZ), *erm*(IP), *erm*(P)   rRNA methylase           738           M36722                       714..1451       *Aggregatibacter*, *Acinetobacter*, *Aerococcus*, *Arcanobacterium*, *Bacillus*, *Bacteroides*, *Citrobacter*, *Corynebacterium*, *Clostridium*, *Enterobacter*, *Escherichia*, *Eubacterium*, *Enterococcus*, *Fusobacterium*, *Gemella*, *Haemophilus*, *Klebsiella*, *Lactobacillus*, *Micrococcus*, *Neisseria*, *Pantoea*, *Pediococcus*, *Peptostreptococcus*, *Porphyromonas*, *Proteus*, *Pseudomonas*, *Ruminococcus*, *Rothia*, *Serratia*, *Staphylococcus*, *Streptococcus*, *Treponema*, *Wolinella*
  *erm*(C)       *erm*(IM), *erm*(M)                                                                     rRNA methylase           735           M19652                       988..1722       *Aggregatibacter*, *Actinomyces*, *Bacillus*, *Bacteroides*, *Corynebacterium*, *Eubacterium*, *Enterococcus*, *Haemophilus*, *Lactobacillus*, *Micrococcus*, *Neisseria*, *Prevotella*, *Peptostreptococcus*, *Staphylococcus*, *Streptococcus*, *Wolinella*
  *erm*(D)       *erm*(J), *erm*(K)                                                                      rRNA methylase           864           M29832                       430..1293       *Bacillus*, *Salmonella*
  *erm*(E)       *erm*(E2)                                                                               rRNA methylase           1,146         X51891                       190..1335       *Bacteroides*, *Eubacterium*, *Fusobacterium*, *Ruminococcus*, *Shigella*, *Streptomyces*
  *erm*(F)       *erm*(FS), *erm*(FU)                                                                    rRNA methylase           801           M14730                       241..1041       *Aggregatibacter*, *Actinomyces*, *Bacteroides*, *Clostridium*, *Corynebacterium*, *Eubacterium*, *Enterococcus*, *Fusobacterium*, *Gardnerella*, *Haemophilus*, *Lactobacillus*, *Mobiluncus*, *Neisseria*, *Porphyromonas*, *Prevotella*, *Peptostreptococcus*, *Ruminococcus*, *Shigella*, *Selenomonas*, *Staphylococcus*, *Streptococcus*, *Treponema*, *Veillonella*, *Wolinella*
  *erm*(G)                                                                                               rRNA methylase           735           M15332                       672..1406       *Bacillus*, *Bacteroides*, *Catenibacterium*, *Lactobacillus*, *Prevotella*, *Porphyromonas*, *Staphylococcus*
  *erm*(H)       *car*(B)                                                                                rRNA methylase           900           M16503                       244..1143       *Streptomyces*
  *erm*(I)       *mdm*(A)                                                                                rRNA methylase                         --                                           *Streptomyces*
  *erm*(N)       *tlr*(D)                                                                                rRNA methylase           876           X97721                       160..1035       *Streptomyces*
  *erm*(O)       *lrm*, *srm*(A)                                                                         rRNA methylase           783           M74717                       40..822         *Streptomyces*
  *erm*(Q)                                                                                               rRNA methylase           774           L22689                       262..1035       *Aggregatibacter*, *Bacteroides*, *Clostridium*, *Staphylococcus*, *Streptococcus*, *Wolinella*
  *erm*(R)                                                                                               rRNA methylase           1,023         M11276                       333..1355       *Arthrobacter*
  *erm*(S)       *erm*(SF), *tlr*(D)                                                                     rRNA methylase           960           M19269                       460..1419       *Streptomyces*
  *erm*(T)       *erm*(GT), *erm*(LF)                                                                    rRNA methylase           735           M64090                       168..902        *Enterococcus*, *Lactobacillus*, *Streptococcus*
  *erm*(U)       *lrm*(B)                                                                                rRNA methylase           837           X62867                       361..1197       *Streptomyces*
  *erm*(V)       *erm*(SV)                                                                               rRNA methylase           780           U59450                       397..1176       *Eubacterium*, *Fusobacterium*, *Streptomyces*
  *erm*(W)       *myr*(B)                                                                                rRNA methylase           936           D14532                       1039..1974      *Micromonospora*
  *erm*(X)       *erm*(CD) *erm*(Y)                                                                      rRNA methylase           855           M36726                       296..1150       *Arcanobacterium*, *Bifidobacterium*, *Corynebacterium*, *Propionibacterium*
  *erm*(Y)       *erm*(GM)                                                                               rRNA methylase           735           AB014481                     556..1290       *Staphylococcus*
  *erm*(Z)       *srm*(D)                                                                                rRNA methylase           849           AM709783                     2817..3665      *Streptomyces*
  *erm*(30)      *pikR1*                                                                                 rRNA methylase           1,011         AF079138                     1283..2293      *Streptomyces*
  *erm*(31)      *pikR2*                                                                                 rRNA methylase           969           AF079138                     154..1122       *Streptomyces*
  *erm*(32)      *tlr*(B)                                                                                rRNA methylase           843           AJ009971                     1790..2632      *Streptomyces*
  *erm*(33)                                                                                              rRNA methylase           732           AJ313523                     163..894        *Staphylococcus*
  *erm*(34)                                                                                              rRNA methylase           846           AY234334                     355..1200       *Bacillus*
  *erm*(35)                                                                                              rRNA methylase           801           AF319779                     33..833         *Bacteroides*
  *erm*(36)                                                                                              rRNA methylase           846           AF462611                     186..1031       *Micrococcus*
  *erm*(37)      *erm*(MT)                                                                               rRNA methylase           540           AE000516                     2229013..       
  2229552        *Mycobacterium*                                                                                                                                                             
  *erm*(38)                                                                                              rRNA methylase           1,161         AY154657                     63..1223        *Mycobacterium*
  *erm*(39)                                                                                              rRNA methylase           741           AY487229                     2153..2893      *Mycobacterium*
  *erm*(40)                                                                                              rRNA methylase           756           AY570506                     2035..2790      *Mycobacterium*
  *erm*(41)                                                                                              rRNA methylase           522           EU590124                     258..779        *Mycobacterium*
  *erm*(42)      *erm*(MI)                                                                               rRNA methylase           906           FR734406                     1..906          *Pasteurella, Photobacterium*
  *lmr*(A)                                                                                               Efflux                   1,446         X59926                       318..1763       *Streptomyces*
  *lnu*(A)       *lin*(A)                                                                                Inactivating enzyme^C^   486           M14039                       413..898        *Clostridium*, *Lactobacillus*, *Staphylococcus*
  *lnu*(B)       *lin*(B)                                                                                Inactivating enzyme^C^   804           AJ238249                     127..930        *Clostridium*, *Enterococcus*, *Staphylococcus*, *Streptococcus*
  *lnu*(C)                                                                                               Inactivating enzyme^C^   495           AY928180                     1150..1644      *Streptococcus*
  *lnu*(D)                                                                                               Inactivating enzyme^C^   495           EF452177                     19..513         *Streptococcus*
  *lnu*(F)       *lin*(F), *lin*(G)                                                                      Inactivating enzyme^C^   822           EU118119                     1030..1851      *Escherichia, Salmonella*
  *lsa*(A)       *abc-23*                                                                                Efflux                   1,497         AY225127                     41..1537        *Enterococcus*
  *lsa*(B)       *orf3*                                                                                  Efflux                   1,479         AJ579365                     4150..5628      *Staphylococcus*
  *lsa*(C)                                                                                               Efflux                   1,479         HM990671                     5193..6671      *Gardnerella*, *Streptococcus*
  *mdf*(A)                                                                                               Other                    1,233         Y08743                       1..1233         *Escherichia, Shigella*
  *mdt*(A)                                                                                               Other                    1,257         X92946                       10534..11790    *Lactococcus*
  *mef*(A)                                                                                               Efflux                   1,218         U70055                       314..1531       *Acinetobacter*, *Bacteroides*, *Citrobacter*, *Clostridium*, *Corynebacterium*, *Enterococcus*, *Enterobacter*, *Escherichia*, *Fusobacterium*, *Gemella*, *Klebsiella*, *Lactobacillus*, *Micrococcus*, *Morganella*, *Neisseria*, *Pantoea*, *Providencia*, *Proteus*, *Ralstonia*, *Pseudomonas*, *Salmonella*, *Serratia*, *Staphylococcus*, *Streptococcus*, *Stenotrophomonas*
  *mef*(B)                                                                                               Efflux                   1,230         FJ196385                     11084..12313    *Escherichia*
  *mef*(E)                                                                                               Efflux                   1,218         U83667                       1..1218         *Enterococcus*, *Fusobacterium*, *Gemella*, *Granulicatella*, *Staphylococcus*, *Streptococcus*
  *mef*(G)                                                                                               Efflux                   1,218         DQ445270                     1..1218         *Streptococcus*
  *mph*(A)       *mph*(K)                                                                                Inactivating enzyme^D^   906           D16251                       1626..2531      *Aeromonas*, *Escherichia*, *Citrobacter*, *Enterobacter*, *Klebsiella*, *Pantoea*, *Pseudomonas*, *Proteus*, *Serratia*, *Shigella*, *Stenotrophomonas*
  *mph*(B)       *mph*(B)                                                                                Inactivating enzyme^D^   909           D85892                       1159..2067      *Escherichia*, *Enterobacter*, *Proteus*, *Pseudomonas*
  *mph*(C)       *mph*(BM)                                                                               Inactivating enzyme^D^   900           AF167161                     5665..6564      *Staphylococcus*, *Stenotrophomonas*
  *mph*(D)                                                                                               Inactivating enzyme^D^   840^§^        AB048591                     1..840          *Escherichia*, *Klebsiella*, *Pantoea*, *Proteus*, *Pseudomonas*, *Stenotrophomonas*
  *mph*(E)       *mph*, *mph1*, *mph2*                                                                   Inactivating enzyme^D^   884           AY522431 AF550415 DQ839391   22181..23064    *Citrobacter, Escherichia*
  *mre*(A)                                                                                               Efflux                   936           U92073                       119..1054       *Streptococcus*
  *msr*(A)       *msr*(B), *msr*(SA)                                                                     Efflux                   1,467         X52085                       343..1809       *Corynebacterium*, *Enterobacter*, *Enterococcus*, *Gemella*, *Pseudomonas*, *Staphylococcus*, *Streptococcus*
  *msr*(C)                                                                                               Efflux                   1,479         AY004350                     496..1974       *Enterococcus*
  *msr*(D)       *mel, orf5*                                                                             Efflux                   1,464         AF274302                     2462..3925      *Acinetobacter*, *Bacteroides*, *Citrobacter*, *Clostridium*, *Corynebacterium*, *Enterococcus*, *Enterobacter*, *Escherichia*, *Gemella*, *Fusobacterium*, *Klebsiella*, *Morganella*, *Neisseria*, *Proteus*, *Providencia*, *Pseudomonas*, *Ralstonia*, *Staphylococcus*, *Streptococcus*, *Serratia*, *Stenotrophomonas*
  *msr*(E)       *mel*                                                                                   Efflux                   1,476         AY522431                     20650..22125    *Citrobacter, Escherichia*
  *ole*(B)                                                                                               Efflux                   1,710         L36601                       1421..3130      *Streptomyces*
  *ole*(C)                                                                                               Efflux                   978           L06249                       1528..2505      *Streptomyces*
  *srm*(B)                                                                                               Efflux                   1,653         X63451                       558..2210       *Streptomyces*
  *tlc*(C)                                                                                               Efflux                   1,647         M57437                       277..1923       *Streptomyces*
  *vat*(A)                                                                                               Inactivating enzyme^C^   660           L07778                       258..917        *Staphylococcus*
  *vat*(B)                                                                                               Inactivating enzyme^C^   639           U19459                       67..705         *Enterococcus*, *Staphylococcus*
  *vat*(C)                                                                                               Inactivating enzyme^C^   639           AF015628                     1307..1945      *Staphylococcus*
  *vat*(D)       *sat*(A)                                                                                Inactivating enzyme^C^   630           L12033                       162..791        *Enterococcus*
  *vat*(E)       *sat*(G), *vat*(E-3)-- *vat*(E-8)                                                       Inactivating enzyme^C^   645           AF139725                     63..707         *Enterococcus*, *Lactobacillus*
  *vat*(F)                                                                                               Inactivating enzyme^C^   666           AF170730                     70..735         *Yersinia*
  *vat*(G)                                                                                               Inactivating enzyme^C^   651           GQ205627                     3037..3687      *Enterococcus*
  *vga*(A)       *vga*                                                                                   Efflux                   1,569         M90056                       909..2477       *Staphylococcus*
  *vga*(A)~LC~   *vga*                                                                                   Efflux                   1,569         DQ823382                     1..1569         *Staphylococcus*
  *vga*(B)                                                                                               Efflux                   1,659         U82085                       629..2287       *Enterococcus*, *Staphylococcus*
  *vga*(C)       *vga*(D)                                                                                Efflux                   1,578         GQ205627                     1394..2971      *Enterococcus*
  *vgb*(A)       *vgb*                                                                                   Inactivating enzyme^B^   900           M20129                       641..1540       *Enterococcus*, *Staphylococcus*
  *vgb*(B)                                                                                               Inactivating enzyme^B^   888           AF015628                     399..1286       *Staphylococcus*

*Adapted from <http://faculty.washington.edu/marilynr/>. ^§^Partial sequence. ^A^Esterase, ^B^Lyase, ^C^Transferase, ^D^Phosphorylase*.

The most common mechanism of MLS resistance is due to the presence of rRNA methylases, encoded by the *erm* genes. These enzymes methylate the adenine residue(s) resulting in MLS resistance. The methylated adenine prevents the binding of the drugs from binding to the 50S ribosomal subunit. The other two mechanisms efflux pumps and inactivating genes are encoded by *msr* and *ere* determinants, respectively.

Because currently over 60 MLS resistance genes are recognized a nomenclature for naming these genes has been proposed that considers the same rules developed for identifying and naming new tetracycline resistance genes (see below; Roberts et al., [@B139]; Roberts, [@B138]). Table [4](#T4){ref-type="table"} represents the MLS acquired resistance genes. The genes included, the resistance mechanism, diverse gene lengths and accession number, and their distribution are displayed in this table.

Quinolone
---------

### History and action mechanism

In 1962, during the process of synthesis and purification of chloroquine (an antimalarial agent), a quinolone derivative, nalidixic acid, was discovered which possessed bactericidal activity against Gram-negatives (Lescher et al., [@B86]). The second generation quinolones arose when it became clear that the addition of a fluoride atom at position 6 of a quinolone molecule, creating a fluoroquinolone, greatly enhanced its biological activity. During the 1980s, various fluoroquinolones were developed, e.g., ciprofloxacin, norfloxacin, and ofloxacin. These fluoroquinolones demonstrated a broadened antimicrobial spectrum, including some Gram-positives (Wolfson and Hooper, [@B176]; Hooper, [@B64]; King et al., [@B78]).

In the 1990s, further alterations resulted in the third-generation (fluoro)quinolones, e.g., levofloxacin and sparfloxacin, showing potent activity against both Gram-negative and Gram-positive microbes. The new compounds, such as trovafloxacin, also show promising activity against anaerobic bacteria (Hooper, [@B64]; King et al., [@B78]).

Quinolones inhibit the action of DNA gyrase and topoisomerase IV, two enzymes essential for bacterial DNA replication and as a result the microbes are killed. (Hooper, [@B63], [@B64]). DNA gyrase is a tetrameric enzyme composed of 2 GyrA and 2 GyrB subunits. The topoisomerase IV has a similar structure, comprised of 2 A and 2 B subunits, encoded by *parC* and *parE*, respectively. The four genes coding for the subunits of these enzymes are the targets for resistance mutations (see below).

### Resistance mechanism

For decades, the mechanisms of resistance to quinolones were believed to be only chromosome-encoded, however, recently three plasmid-mediated resistance mechanisms have been reported (Robicsek et al., [@B140]; Courvalin, [@B37]; Martínez-Martínez et al., [@B97]). The chromosome-encoded resistance result in either a decreased outer-membrane permeability related to porin loss, to the (over)expression of naturally occurring efflux pumps or mutations of the molecular targets DNA gyrase and topoisomerase IV (Hooper, [@B64]; Ruiz, [@B143]; Jacoby, [@B71]). In the latter case mutations occur at specific "quinolone resistance determining regions" (QRDR) in the genes *gyrA*, *gyrB*, *parC*, and *parE* encoding the subunits of DNA gyrase and topoisomerase IV. Not surprisingly this QRDR is situated on the DNA-binding surface of the enzymes (Jacoby, [@B71]).

Although the possibility of the existence of plasmid-mediated resistance was already suggested in 1990 (Courvalin, [@B36]), the first actually identified plasmid-mediated quinolone resistance gene, a *qnr* determinant, which encodes for a protein that protects DNA gyrase and type IV topoisomerase from quinolone inhibition, was reported nearly a decade later (Martínez-Martínez et al., [@B98]).

Currently five families of *qnr* genes have been reported; *qnrA* (7), *qnrB* (39), *qnrC* (1), *qnrD* (1), and *qnrS* (4). The number in between brackets indicates the variants known of each type (Jacoby et al., [@B70]; Cattoir and Nordmann, [@B27]; Cavaco et al., [@B29]; Strahilevitz et al., [@B158]; Torpdahl et al., [@B163]). Because of the increasing number of *qnr* genes a database has been constructed and will be maintained to assign further allele numbers to novel variants[^2^](#fn2){ref-type="fn"}. Very recently an additional family has been described, qnrAS in the fish pathogen *Aliivibrio salmonicida* (Sun et al., [@B159]). Table [5](#T5){ref-type="table"} describes all known *qnr* families and their variants, together with the gene lengths, accession numbers, and in which bacterial genera they have been identified so far.

###### 

**Acquired quinolone resistance genes**.

  Gene\*                                   Length (nt)   Accession number   Coding region      Genera
  ---------------------------------------- ------------- ------------------ ------------------ ----------------------------------------------------------------------------------
  *qepA*                                   1,536         AB263754           7052..8587         *Escherichia*
  *qepA2*                                  1,536         EU847537           1672..3207         *Escherichia*
  *qnrA1*                                  657           AY070235           303..959           *Citrobacter*, *Enterobacter*, *Escherichia*, *Klebsiella*, *Shigella*
  *qnrA2*                                  657           AY675584           1..657             *Klebsiella*, *Shewanella*
  *qnrA3*                                  657           DQ058661           1..657             *Shewanella*
  *qnrA4*                                  657           DQ058662           1..657             *Shewanella*
  *qnrA5*                                  657           DQ058663           1..657             *Shewanella*
  *qnrA6*                                  657           DQ151889           1..657             *Proteus*
  *qnrA7*                                  657           GQ463707           1..657             *Shewanella*
  *qnrAS*                                  657           FM178379           1699484..1700140   *Aliivibrio*
  *qnrB1*                                  645           DQ351241           37..681            *Enterobacter*, *Escherichia*, *Klebsiella*
  *qnrB2*                                  645           DQ351242           1..645             *Citrobacter*, *Enterobacter*,, *Klebsiella*, *Salmonella*
  *qnrB3*                                  645           DQ303920           37..681            *Escherichia*
  *qnrB4*                                  645           DQ303921           4..648             *Citrobacter, Enterobacter*, *Escherichia*, *Klebsiella*
  *qnrB5*                                  645           DQ303919           37..681            *Enterobacter*, *Salmonella*
  *qnrB6*                                  645           EF520349           37..681            *Enterobacter*, *Escherichia*, *Klebsiella*, *Pantoea*
  *qnrB7*                                  645           EU043311           1..645             *Enterobacter*, *Klebsiella*
  *qnrB8*                                  645           EU043312           1..645             *Citrobacter*, *Enterobacter*
  *qnrB9*                                  645           EF526508           1..645             *Citrobacter*
  *qnrB10*                                 645           DQ631414           37..681            *Citrobacter*, *Enterobacter*, *Escherichia*, *Klebsiella*
  *qnrB11*                                 645           EF653270           4..648             *Citrobacter*
  *qnrB12*                                 645           AM774474           2435..3079         *Citrobacter*
  *qnrB13*                                 645           EU273756           37..681            *Citrobacter*
  *qnrB14*                                 645           EU273757           37..681            *Citrobacter*
  *qnrB15*                                 645           EU302865           37..681            *Citrobacter*
  *qnrB16*                                 645           EU136183           37..681            *Citrobacter*
  *qnrB17*                                 645           AM919398           37..681            *Citrobacter*
  *qnrB18*                                 645           AM919399           37..681            *Citrobacter*
  *qnrB19*                                 645           EU432277           1..645             *Escherichia*, *Klebsiella*, *Salmonella*
  *qnrB20*                                 645           AB379831           37..681            *Escherichia*, *Klebsiella*
  *qnrB21*                                 645           FJ611948           1..645             *Escherichia*
  *qnrB22*                                 645           FJ981621           37..681            *Citrobacter*
  *qnrB23*                                 645           FJ981622           37..681            *Citrobacter*
  *qnrB24*                                 645           HM192542           37..681            *Citrobacter*
  *qnrB25*                                 645           HQ172108           1..645             *Citrobacter*
  *qnrB26*                                 645           HM439644           1..645             *Citrobacter*
  *qnrB27*                                 645           HM439641           1..645             *Citrobacter*
  *qnrB28*                                 645           HM439643           1..645             *Citrobacter*
  *qnrB29*                                 645           HM439649           37..681            *Citrobacter*
  *qnrB30*                                 645           HM439650           37..681            *Citrobacter*
  *qnrB31*                                 645           HQ418999           1..681             *Klebsiella*
  ***qnrB32*-- *qnrB39* not public yet**                                                       
  *qnrC*                                   666           EU917444           1717..2382         *Proteus*
  *qnrD*                                   645           EU692908           1..645             *Salmonella*
  *qnrS1*                                  657           AB187515           9737..10393        *Enterobacter*, *Escherichia*, *Klebsiella*, *Proteus*, *Salmonella*, *Shigella*
  *qnrS2*                                  657           DQ485530           1..657             *Aeromonas*, *Salmonella*
  *qnrS3*                                  657           EU077611           1..656             *Escherichia*
  *qnrS4*                                  657           FJ418153           1..657             *Salmonella*

*\*Last update: June 17th 2011*.

The second type of plasmid located quinolone resistant gene is a cr variant of *aac(6*′*)-Ib*, *aac(6*′*)-Ib-cr*, responsible for low-level ciprofloxacin resistance. It encodes an aminoglycoside acetyltransferase, called AAC(6′)-Ib-cr which has two amino acid changes, Trp102Arg and Asp179Tyr. These substitutions are responsible for the enzyme's ability to acetylate ciprofloxacin (Park et al., [@B116]; Robicsek et al., [@B141]; Strahilevitz et al., [@B158]).

The third mechanism is *qepA*, a plasmid-mediated efflux pump which can extrude hydrophilic fluoroquinolones, e.g., ciprofloxacin and enrofloxacin (Périchon et al., [@B120]; Yamane et al., [@B183]). A variant of this resistance pump, QepA2, was identified in an *E. coli* isolate from France (Cattoir et al., [@B28]).

Streptothricin
--------------

### History and action mechanism

In the early days of the antibiotics era screening for new compound resulted in the discovery of a *Streptomyces lavendulae* isolate which inhibited growth of Gram-negative as well as Gram-positive bacteria. Isolation of the active antimicrobial substance resulted in the identification of streptothricin (Waksman and Woodruff, [@B169]). Delayed toxicity prevents streptothricin's use in man, but it is effective in preventing animal infections.

Streptothricins consist of three moieties: gulosamine, streptolidin, and a β-lysine peptide chain. Since, the discovery of the streptothricin, six analogs have been reported, streptothricin A--F. The analogs differ from the parent molecule in the number of β-lysine residues (Keeratipibul et al., [@B77]; Tschäpe et al., [@B164]).

The streptothricins are potent inhibitors of bacterial protein synthesis, via direct binding to ribosomes. They also cause misreading of mRNA codons, although they are unrelated to other drugs that cause translational ambiguity, like the aminoglycosides (Tschäpe et al., [@B164]).

### Resistance mechanism

Since streptothricin is inactivated by acetylation in its producer it is not surprising that the identified resistance mechanisms are acetyltransferases. The first streptothricin resistant bacterium identified was an *E. coli* isolate from a rectal swab of pigs under streptothricin F treatment. The AR gene was localized on a transferable plasmid (Tschäpe et al., [@B164]). Currently three different streptothricin acetyltransferases are recognized, *sat2*--*sat4* (Partridge and Hall, [@B117]; see Table [1](#T1){ref-type="table"}).

Sulfonamide
-----------

### History and action mechanism

Sulfonamides belong to the oldest introduced synthetic drugs. They were first used in 1932 (Domagk, [@B47]; Sköld, [@B151]). A number of different sulfonamides have been developed of which the most commonly used nowadays is sulfamethoxazole. Moreover, since 1968, the combination of trimethoprim and sulfamethoxazole (called co-trimoxazole) has been used extensively because a combination of both drugs at certain concentrations has a synergetic bactericidal effect, it reduces selection of AR to either drug and associated costs (Roberts, [@B136]; Grape, [@B59]).

A sulfonamide, with its structural analogy to *p*-aminobenzoic acid, which is involved in the biosynthetic pathway leading to folic acid, competitively inhibits the enzyme dihydropteroate synthase (DHPS). This protein is part of the next to last step of the folate biosynthetic pathway that is required for thymine production and bacterial cell growth (Sköld, [@B150], [@B151]; Roberts, [@B136]).

### Resistance mechanism

Resistance to sulfonamide among pathogenic bacteria appeared quite soon after its introduction into clinical practice in the 1930s (Sköld, [@B151]). Since sulfonamides are synthetic antibacterial agents, naturally occurring enzymes degrading, or modifying this drug were not to be expected. However, chromosomal sulfonamide resistance occurs, mostly low level, by mutations in the *folP* gene encoding DHPS (Huovinen et al., [@B68]; Sköld, [@B150], [@B151]; Grape, [@B59]).

Acquired sulfonamide resistance was discovered in the 1960s, but the plasmid-mediated genes were characterized later on in the 1980s as *sul1* and *sul2* (Swedberg and Sköld, [@B161]; Rådström and Swedberg, [@B127]; Sundström et al., [@B160]). Currently three plasmid-borne drug-resistant variants of the DHPS enzymes are known; besides the two genes mentioned above also *sul3* has been identified (Perreten and Boerlin, [@B121]).

Tetracycline
------------

### History and action mechanism

The first tetracycline antibiotic was characterized in 1948 as chlortetracycline from *Streptomyces aureofaciens* (Chopra et al., [@B33]; Chopra and Roberts, [@B34]). In consecutive decades additional tetracyclines were identified either as naturally occurring molecules mostly in *Streptomyces* species (e.g., oxytetracycline, tetracycline) or products of semi-synthetic approaches (e.g., doxycycline, minocycline; Chopra et al., [@B33]; Hunter and Hill, [@B66]; Chopra and Roberts, [@B34]).

Tetracyclines were the first major group to which the term "broad spectrum" was applied (Chopra and Roberts, [@B34]). Because of this spectrum of activity, their relative safety, and low cost, tetracyclines have been used widely throughout the world and are second after penicillin in world consumption. This class of antibiotic can be separated into two groups, typical, (e.g., chlortetracycline, doxycycline, minocycline, oxytetracycline, and tetracycline) and atypical tetracyclines (e.g., anhydrotetracycline and 6-thiatetracycline), see below (Rasmussen et al., [@B129]; Oliva and Chopra, [@B112]; Chopra and Roberts, [@B34]).

Initially, it was thought that tetracyclines and most of its derivatives are antimicrobial agents only because they inhibit the growth of microbes by entering the bacterial cell, interacting with the ribosomes, and consequently blocking protein synthesis, the so-called typical tetracyclines (Speer et al., [@B154]; Roberts, [@B136]). However, Oliva and Chopra ([@B112]) suggested an additional mode of action. Certain tetracycline derivatives are poor inhibitors of protein synthesis and appear to bind ribosomes inefficiently or not at all, in stead they interact with the bacterial membrane (Rasmussen et al., [@B129]; Chopra, [@B32]).

### Resistance mechanism

Prior to the mid-1950s, the majority of commensals and pathogens were susceptible to tetracycline. However, in 1953 the first tetracycline resistant bacteria were isolated (Watanabe, [@B170]). The resistance mechanisms for the tetracycline class of antibiotics fall in three categories; energy-dependent efflux pumps, ribosomal protection proteins (RPPs), or enzymatic inactivation.

A novel tetracycline resistance determinant is identified as unique if it shares \<79% amino sequence identity with all previously described genes. Initially, letters of the Roman alphabet have been used to name tetracycline resistance determinants. However, the number of *tet* genes has reached the end of the alphabet and to accommodate new genes, a nomenclature employing numerals for future determinants was introduced (Levy et al., [@B88]). Moreover, also naturally occurring hybrid tetracycline resistance genes exist. A simple, descriptive nomenclature for these mosaic *tet* determinants has been proposed incorporating the designations of the known tet genes classes forming the hybrid, e.g., *tet*(O/W) and *tet*(O/W/O; Levy et al., [@B89]; Stanton et al., [@B156]; van Hoek et al., [@B167]).

There are currently over 40 different acquired tetracycline resistance determinants recognized, i.e., 38 *tet* (tetracycline resistance) and 3 *otr* (oxytetracycline resistance) genes, additionally 1 *tcr* gene has been identified (Roberts, [@B135], [@B137]; Brown et al., [@B15]; see Table [6](#T6){ref-type="table"}). Among these 25 of the *tet*, 2 of the *otr* genes and the only *tcr* determinant code for efflux pumps, whereas 10 *tet* and 1 *otr* code for a RPP. The enzymatic inactivation mechanism can be attributed to 3 *tet* genes. The *tet*(U) determinant represents an unknown tetracycline resistance mechanism since its sequence does not appear to be related to either efflux or RPPs, nor to the inactivation enzymes (Table [6](#T6){ref-type="table"}). The efflux and RPP encoding genes are found in members of Gram-positive, Gram-negative, aerobic, as well as anaerobic bacterial species. In contrast the enzymatic tetracycline inactivation mechanism has so far only been identified in Gram-negatives (Table [6](#T6){ref-type="table"}). The *tet*(M) has the broadest host range of all tetracycline resistance genes, whereas *tet*(B) gene has the widest range among the Gram-negative microbes. In recent years published data indicate that there are increasing numbers of Gram-negative bacteria that carry "Gram-positive *tet* genes" (Roberts, [@B136]).

###### 

**Acquired tetracycline resistance genes**.

  Gene        Mechanism              Length (nt)   Accession number   Coding region   Genera
  ----------- ---------------------- ------------- ------------------ --------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *otr*(A)    Ribosomal protection   1,992         X53401             349..2340       *Mycobacterium*, *Streptomyces*
  *otr*(B)    Efflux                 1,692         AF079900           40..1731        *Mycobacterium*, *Streptomyces*
  *otr*(C)    Efflux                 1,056         AY509111           324..1379       *Streptomyces*
  *tcr*       Efflux                 1,539         D38215             516..2054       *Streptomyces*
  *tet*(A)    Efflux                 1,200         X00006             1328..2527      *Acinetobacter*, *Aeromonas*, *Bordetella*, *Chryseobacterium*, *Citrobacter*, *Edwardsiella*, *Enterobacter*, *Escherichia*, *Flavobacterium*, *Klebsiella*, *Laribacter*, *Plesiomonas*, *Proteus*, *Pseudomonas*, *Salmonella*, *Serratia*, *Shigella*, *Variovorax*, *Veillonella*, *Vibrio*
  *tetA*(P)   Efflux                 1,263         L20800             1063..2325      *Clostridium*
  *tet*(B)    Efflux                 1,206         J01830             1608..2813      *Acinetobacter*, *Actinobacillus*, *Aeromonas*, *Aggregatibacter*, *Brevundimonas*, *Citrobacter*, *Enterobacter*, *Erwinia*, *Escherichia*, *Haemophilus*, *Klebsiella*, *Mannheimia*, *Moraxella*, *Neisseria*, *Pantoea*, *Pasteurella*, *Photobacterium*, *Plesiomonas*, *Proteus*, *Providencia*, *Pseudomonas*, *Roseobacter*, *Salmonella*, *Serratia*, *Shigella*, *Treponema*, *Vibrio*, *Yersinia*
  *tet*B(P)   Ribosomal protection   1,959         L20800             2309..4267      *Clostridium*
  *tet*(C)    Efflux                 1,191         X01654             86..1276        *Aeromonas*, *Bordetella*, *Chlamydia*, *Citrobacter*, *Enterobacter*, *Escherichia*, *Francisella*, *Halomonas*, *Klebsiella*, *Proteus*, *Pseudomonas*, *Roseobacter*, *Salmonella*, *Serratia*, *Shigella*, *Vibrio*
  *tet*(D)    Efflux                 1,185         X65876             1521..2705      *Aeromonas*, *Alteromonas*, *Citrobacter*, *Edwardsiella*, *Enterobacter*, *Escherichia*, *Halomonas*, *Klebsiella*, *Morganella*, *Pasteurella*, *Photobacterium*, *Proteus*, *Salmonella*, *Shewanella*, *Shigella*, *Vibrio*, *Yersinia*
  *tet*(E)    Efflux                 1,218         L06940             21..1238        *Aeromonas*, *Alcaligenes*, *Escherichia*, *Flavobacterium*, *Plesiomonas*, *Proteus*, *Providencia*, *Pseudomonas*, *Roseobacter*, *Serratia*, *Vibrio*
  *tet*(G)    Efflux                 1,128         AF071555           6644..7771      *Acinetobacter*, *Brevundimonas*, *Escherichia*, *Fusobacterium*, *Mannheimia*, *Ochrobactrum*, *Pasteurella*, *Proteus*, *Providencia*, *Pseudomonas*, *Roseobacter*, *Salmonella*, *Shewanella*, *Vibrio*
  *tet*(H)    Efflux                 1,203         U00792             716..1918       *Acinetobacter*, *Actinobacillus*, *Mannheimia*, *Moraxella*, *Pasteurella*
  *tet*(J)    Efflux                 1,197         AF038993           1084..2280      *Escherichia*, *Morganella*, *Proteus*
  *tet*(K)    Efflux                 1,380         M16217             305..1684       *Bacillus*, *Clostridium*, *Enterococcus*, *Eubacterium*, *Haemophilus*, *Lactobacillus*, *Listeria*, *Mycobacterium*, *Nocardia*, *Nocardia*, *Peptostreptococcus*, *Staphylococcus*, *Streptococcus*, *Streptomyces*
  *tet*(L)    Efflux                 1,377         D00006             189..1565       *Acinetobacter*, *Actinobacillus*, *Actinomyces*, *Bacillus*, *Bifidobacterium*, *Citrobacter*, *Clostridium*, *Enterobacter*, *Enterococcus*, *Escherichia*, *Flavobacterium*, *Fusobacterium*, *Geobacillus*, *Kurthia*, *Lactobacillus*, *Listeria*, *Mannheimia*, *Morganella*, *Mycobacterium*, *Nocardia*, *Ochrobactrum*, *Oceanobacillus, Paenibacillus*, *Pasteurella*, *Pediococcus*, *Peptostreptococcus*, *Proteus*, *Pseudomonas*, *Rahnella*, *Salmonella*, *Sporosarcina*, *Staphylococcus*, *Streptococcus*, *Streptomyces*, *Variovorax*, *Veillonella*, *Virgibacillus*
  *tet*(M)    Ribosomal protection   1,920         U08812             1981..3900      *Abiotrophia*, *Acinetobacter*, *Actinomyces*, *Aerococcus*, *Aeromonas*, *Afipia*, *Arthrobacter*, *Bacillus*, *Bacterionema*, *Bacteroides*, *Bifidobacterium*, *Brachybacterium, Catenibacterium*, *Clostridium*, *Corynebacterium*, *Edwardsiella*, *Eikenella*, *Enterobacter*, *Enterococcus*, *Erysipelothrix*, *Escherichia*, *Eubacterium*, *Flavobacterium*, *Fusobacterium*, *Gardnerella*, *Gemella*, *Granulicatella*, *Haemophilus*, *Kingella, Klebsiella*, *Kurthia*, *Lactobacillus*, *Lactococcus, Listeria*, *Microbacterium*, *Mycoplasma*, *Neisseria*, *Paenibacillus*, *Pantoea*, *Pasteurella*, *Peptostreptococcus*, *Photobacterium*, *Prevotella*, *Pseudoalteromonas, Pseudomonas*, *Ralstonia*, *Selenomonas*, *Serratia*, *Shewanella, Staphylococcus*, *Streptococcus*, *Streptomyces*, *Ureaplasma*, *Veillonella*, *Vibrio*
  *tet*(O)    Ribosomal protection   1,920         M18896             207..2126       *Actinobacillus*, *Aerococcus*, *Anaerovibrio*, *Bifidobacterium*, *Butyrivibrio*, *Campylobacter*, *Clostridium*, *Enterococcus*, *Eubacterium*, *Fusobacterium*, *Gemella*, *Lactobacillus*, *Megasphaera*, *Mobiluncus*, *Neisseria*, *Peptostreptococcus*, *Psychrobacter*, *Staphylococcus*, *Streptococcus*
  *tet*(Q)    Ribosomal protection   1,926         Z21523             362..2287       *Anaerovibrio*, *Bacteroides*, *Capnocytophaga*, *Clostridium*, *Eubacterium*, *Fusobacterium*, *Gardnerella*, *Lactobacillus*, *Mitsuokella*, *Mobiluncus*, *Neisseria*, *Peptostreptococcus*, *Porphyromonas*, *Prevotella*, *Ruminococcus*, *Selenomonas*, *Streptococcus*, *Subdoligranulum*, *Veillonella*
  *tet*(S)    Ribosomal protection   1,926         L09756             447..2372       *Enterococcus*, *Lactobacillus*, *Lactococcus, Listeria*, *Staphylococcus*, *Streptococcus*, *Veillonella*
  *tet*(T)    Ribosomal protection   1,956         L42544             478..2433       *Lactobacillus*, *Streptococcus*
  *tet*(U)    Unknown                318           U01917             413..730        *Enterococcus*, *Staphylococcus*, *Streptococcus*
  *tet*(V)    Efflux                 1,260         AF030344           462..1721       *Mycobacterium*
  *tet*(W)    Ribosomal protection   1,920         AJ222769           3687..5606      *Acidaminococcus*, *Actinomyces*, *Arcanobacterium*, *Bacillus*, *Bacteroides*, *Bifidobacterium*, *Butyrivibrio*, *Clostridium*, *Fusobacterium*, *Lactobacillus*, *Megasphaera*, *Mitsuokella*, *Neisseria*, *Porphyromonas*, *Prevotella*, *Roseburia*, *Selenomonas*, *Staphylococcus*, *Streptococcus*, *Streptomyces*, *Subdoligranulum*, *Veillonella*
  *tet*(X)    Enzymatic              1,167         M37699             586..1752       *Bacteroides*, *Sphingobacterium*
  *tet*(Y)    Efflux                 1,176         AF070999           1680..2855      *Aeromonas*, *Escherichia*, *Photobacterium*
  *tet*(Z)    Efflux                 1,155         AF121000           11880..13034    *Corynebacterium*, *Lactobacillus*
  *tet*(30)   Efflux                 1,185         AF090987           1130..2314      *Agrobacterium*
  *tet*(31)   Efflux                 1,233         AJ250203           1651..2883      *Aeromonas*
  *tet*(32)   Ribosomal protection   1,920         DQ647324           181..2100       *Enterococcus*, *Eubacterium*, *Clostridium*, *Streptococcus*
  *tet*(33)   Efflux                 1,224         AJ420072           22940..24163    *Corynebacterium*
  *tet*(34)   Enzymatic              465           AB061440           306..770        *Aeromonas*, *Pseudomonas*, *Serratia*, *Vibrio*
  *tet*(35)   Efflux                 1,110         AF353562           2213..3322      *Stenotrophomonas*, *Vibrio*
  *tet*(36)   Ribosomal protection   1,923         AJ514254           2534..4456      *Bacteroides*, *Clostridium*, *Lactobacillus*
  *tet*(37)   Enzymatic              327           AF540889           1..327          Uncultured
  *tet*(38)   Efflux                 1,353         AY825285           1..1353         *Staphylococcus*
  *tet*(39)   Efflux                 1,188         AY743590           749..1936       *Acinetobacter*
  *tet*(40)   Efflux                 1,221         AM419751           14211..15431    *Clostridium*
  *tet*(41)   Efflux                 1,182         AY264780           1825..3006      *Serratia*
  *tet*(42)   Efflux                 1,287         EU523697           687..1973       *Bacillus*, *Microbacterium*, *Micrococcus*, *Paenibacillus*, *Pseudomonas*, *Staphylococcus*
  *tet*(43)   Efflux                 1,560         GQ244501           60..1619        Uncultured
  *tet*(44)   Ribosomal protection   1,923         FN594949           25245..27167    *Campylobacter*

Adapted from <http://faculty.washington.edu/marilynr/>

Trimethoprim
------------

### History and action mechanism

Trimethoprim has been available since 1962 and is considered the last truly new antibacterial agent introduced into clinical practice (Roth et al., [@B142]). All later developed agents have been variations of older antibiotics, that is, belonging to families of agents, within which cross-resistance is common (Sköld, [@B151]; Roberts, [@B136]). Trimethoprim is a completely synthetic drug, belonging to the diaminopyrimidine group of compounds, i.e., 5-benzyl-2,4-diamino-pyrimidine (Huovinen, [@B67]).

Trimethoprim inhibits the enzyme dihydrofolate reductase (DHFR) by competitively binding to its active site. DHFR catalysis the NAHPH-dependent reduction of dihydrofolate acid to the active co-enzyme tetrahydrofolate. As such trimethoprim can be regarded as an antifolate, a structural analog of folic acid. DHFR, like DHPS is part of the folate biosynthetic pathway (Sköld, [@B151]; Grape, [@B59]; see section Sulfonamides).

### Resistance mechanism

Because trimethoprim like sulfonamide is a synthetic antibacterial agent, naturally occurring enzymes degrading, or modifying it are unlikely. However, resistance, mostly low level, can for example occur via non-allelic and drug-resistant variants of the chromosomal *folA* gene encoding the bacterial DHFR (Huovinen et al., [@B68]; Sköld, [@B151]; Grape, [@B59]).

High-level resistance is generally achieved by a bypass mechanism through the action of an acquired gene which is a non-allelic and drug-insusceptible variant of a chromosomal DHFR. These plasmid-mediated DHFRs emerged in Gram-negative bacteria within several years of the clinical introduction of the drug (Fleming et al., [@B51]; Huovinen and Toivanen, [@B69]; Amyes and Towner, [@B8]).

Initially, the acquired DHFRs fell into two quite distinct families, *dfrA* and *dfrB* genes (Howell, [@B65]). Members of the *dfrA* group are at least 474 nucleotides (nt) long (157 amino acids, aa), whereas the *dfrB* genes are 237 nt in length (78 aa). Currently six plasmid-mediated families can be distinguished with relatively few *dfr* determinants originating from Gram-positive bacteria. (Table [7](#T7){ref-type="table"}). The *dfrK* gene is the newest addition to the trimethoprim resistance determinant family (Kadlec and Schwarz, [@B76]). In contrast to the latest reported DHFRs, the oldest families, *dfrA* and *dfrB*, each contain several members (Roberts, [@B136]; Levings et al., [@B87]). For example, the *dfrA* group accommodates over 30 genes. Determinant *dfrA27* is the newest reported DHFR gene among Gram-negatives (Wei et al., [@B171]), although a newer, however unpublished, *dfrA* variant is present in the public DNA library and some genes apparently have changed nomenclature (Table [7](#T7){ref-type="table"}). Among this family two sub-families can be distinguished (Adrian et al., [@B5]). The *dfrA1*-group with 12 different genes share 64--90% identity on amino acids level. The *dfrA12*-group, with five members, display 84% amino acid identity and similar trimethoprim-inhibition profiles. The additional *dfrA* genes are less related to each other, some have even less than 25% amino acid sequence identity. In contrast to the *dfrA* family, the *dfrB* group is somewhat smaller, with only eight reported genes (Levings et al., [@B87]; Partridge et al., [@B118]).

###### 

**Acquired trimethoprim resistance genes**.

  Gene       Sub-family       Gene(s) included                Length (nt)   Accession number   Coding region   Genera
  ---------- ---------------- ------------------------------- ------------- ------------------ --------------- ---------------------------------------------------------------------------------------------------------------------------------------------------
  *dfrA1*    *dfrA1*-group    *dhfrIb*, *dfr1*, *dhfrI*       474           X00926             236..709        *Actinobacter*, *Enterobacter*, *Escherichia*, *Klebsiella*, *Morganella*, *Proteus*, *Pseudomonas*, *Salmonella, Serratia*, *Shigella*, *Vibrio*
  *dfrA3*                                                     489           J03306             103..591        *Salmonella*
  *dfrA5*    *dfrA1*-group    *dhfrV*, *dfrV*                 474           X12868             1306..1779      *Aeromonas*, *Enterobacter*, *Escherichia*, *Klebsiella*, *Salmonella, Vibrio*
  *dfrA6*    *dfrA1*-group    *dfrVI*                         474           Z86002             336..809        *Escherichia*, *Proteus, Vibrio*
  *dfrA7*    *dfrA1*-group    *dhfrVII*, *dfrVII*, *dfrA17*   474           X58425             594..1067       *Actinobacter*, *Escherichia*, *Proteus*, *Salmonella*, *Shigella*
  *dfrA8*                                                     510           U10186             711..1220       *Shigella*
  *dfrA9*                                                     534           X57730             726..1259       *Escherichia*
  *dfrA10*                                                    564           L06418             5494..6057      *Actinobacter*, *Escherichia*, *Klebsiella*, *Salmonella*
  *dfrA12*   *dfrA12*-group   *dhfrXII*, *dfr12*              498           Z21672             310..807        *Actinobacter*, *Aeromonas*, *Enterobacter*, *Enterococcus*, *Citrobacter*, *Klebsiella*, *Pseudomonas*, *Serratia*, *Salmonella, Staphylococcus*
  *dfrA13*   *dfrA12*-group                                   498           Z50802             718..1215       *Escherichia*
  *dfrA14*   *dfrA1*-group    *dhfrIb*                        474           Z50805             72..545         *Achromobacter*, *Aeromonas*, *Escherichia*, *Klebsiella*, *Salmonella, Vibrio*
  *dfrA15*   *dfrA1*-group    *dhfrXVb*                       474           Z83311             357..830        *Enterobacter*, *Klebsiella*, *Morganella*, *Proteus*, *Pseudomonas*, *Salmonella, Vibrio*
  *dfrA16*   *dfrA1*-group    *dhfrXVI*, *dfr16*              474           AF077008           115..588        *Aeromonas*, *Escherichia*, *Salmonella*
  *dfrA17*   *dfrA1*-group    *dhfrXVII*, *dfr17*             474           AB126604           98..571         *Actinobacter*, *Enterobacter*, *Klebsiella*, *Pseudomonas*, *Salmonella, Serratia*, *Shigella*, *Staphylococcus*
  *dfrA18*                    *dfrA19*                        570           AJ310778           7004..7573      *Enterobacter*, *Klebsiella*, *Salmonella*
  *dfrA20*                                                    510           AJ605332           1304..1813      *Pasteurella*
  *dfrA21*   *dfrA12*-group   *dfrxiii*                       498           AY552589           1..498          *Klebsiella*, *Salmonella*
  *dfrA22*   *dfrA12*-group   *dfr22*, *dfr23*                498           AJ628423           325..822        *Escherichia*, *Klebsiella*
  *dfrA23*                                                    561           AJ746361           6743..7303      *Salmonella*
  *dfrA24*                                                    558           AJ972619           83..640         *Escherichia*
  *dfrA25*   *dfrA1*-group                                    459           DQ267940           54..512         *Citrobacter*, *Salmonella*
  *dfrA26*                                                    552           AM403715           303..854        *Escherichia*
  *dfrA27*   *dfrA1*-group    *dfr*                           474           EU675686           2543..3016      *Escherichia*
  *dfrA28*   *dfrA1*-group                                    474           FM877476           116..589        *Aeromonas*
  *dfrA29*                    *dfrVII*, *dfrA7*               472           AM237806           615..1086       *Salmonella*
  *dfrA30*                    *dhfrV*                         474           AM997279           705..1178       unknown
  *dfrA31*                    *dfr6*                          474           AB200915           1832..2305      *Vibrio*
  *dfrA32*   *dfrA1*-group                                    474           GU067642           535..1008       *Laribacter*, *Salmonella*
  *dfrA33*   *dfrA12*-group                                   498           FM957884           88..585         Unknown
  *dfrB1*                     *dhfrIIa*, *dfr2a*              237           U36276             717..953        *Aeromonas*, *Bordetella*, *Escherichia*, *Klebsiella*
  *dfrB2*                     *dhfrIIb*, *dfr2b*              237           J01773             809..1045       *Escherichia*
  *dfrB3*                     *dhfrIIc*, *dfr2c*              237           X72585             5957..6193      *Aeromonas*, *Enterobacter*, *Escherichia*, *Klebsiella*
  *dfrB4*                     *dfr2d*                         237           AJ429132           69..305         *Aeromonas*, *Escherichia*, *Klebsiella*
  *dfrB5*                     *dfr2e*                         237           AY943084           2856..3092      *Pseudomonas*
  *dfrB6*                                                     237           DQ274503           394..630        *Salmonella*
  *dfrB7*                                                     237           DQ993182           244..480        *Aeromonas*
  *dfrB8*                                                     249           GU295656           1048..1296      *Aeromonas*
  *dfrC*                      *dfrA*                          486           Z48233             337..822        *Staphylococcus*
  *dfrD*                                                      489           Z50141             94..582         *Listeria*, *Staphylococcus*
  *dfrG*                                                      498           AB205645           1013..1510      *Enterococcus*, *Staphylococcus*
  *dfrK*                                                      492           FM207105           2788..3279      *Staphylococcus*

*Partly adapted from Grape ([@B59]), Partridge et al. ([@B118])*.

Mobile Genetic Elements
=======================

Acquired AR genes are frequently contained within mobile DNA which can be loosely defined as any segment of DNA that is capable of translocation from one part of a genome to another or between genomes. This definition includes a wide range of distinct mobile elements. The major players in HGT are the conjugative and mobilizable elements, the former contain all the genetic information required to transfer from one bacterium to another whilst the latter use the conjugation functions of co-resident conjugative elements (conjugative plasmids or conjugative transposons) to transfer to another host. Bacteriophages also play a role in the spread of DNA between bacteria, they do this by a process called transduction in which bacterial DNA, rather than phage DNA, is packaged into the phage head and injected into the recipient bacterium. There are also elements which are capable of translocation to new sites in the genome but are not themselves capable of transfer to a new host (of course if they transpose to a conjugative element they can be moved to new hosts). These include the transposons and the mobile introns.

Bacteria can also acquire AR genes by transformation. The process occurs in both Gram-positive and Gram-negative bacteria. Bacteria capable of taking up DNA from the environment are termed "competent." Some microorganisms, such as many streptococci, are competent at a specific stage in their growth whilst others have no obvious competence window. Some bacteria have specific sequence requirements to successfully take up DNA such as *Neisseria* (Smith et al., [@B153]), while others like *Bacillus subtilis* have no obvious such requirements. In this process naked DNA is taken up by the recipient bacteria and either incorporated into the host genome by homologous recombination or transposition. Alternatively the DNA molecule may be able to replicate autonomously, e.g., plasmids. Mobile genetic elements are often acquired by transformation as well as by conjugation. For a recent review of the mechanisms of transformation see (Kovács et al., [@B84]; Aune and Aachmann, [@B10]; Burton and Dubnau, [@B16]).

Conjugative elements (plasmids)
-------------------------------

Typically plasmids are extra chromosomal elements that contain their own origin of replication. They have been found in almost all bacterial genera and the simplest of these elements just contain an origin of replication and genes encoding replication functions, e.g., see Chambers et al. ([@B31]). Plasmids also commonly contain an origin of transfer and genes encoding functions that allow them to transfer to new hosts via conjugation (Smillie et al., [@B152]). Plasmids that harbor conjugation genes are called conjugative and plasmids that only contain an origin of transfer (*oriT*) but no conjugation genes are called mobilizable as they can make use of the conjugation functions of conjugative plasmids to transfer to a new host.

In addition to functions involved in replication and transfer plasmids commonly encode resistance to antibiotics. If a resistance gene is on a conjugative or mobilizable plasmid then it has the potential to transfer to new hosts. Some plasmids have a broad host range and can transfer between different species whereas others have a much narrower host range and are confined to one genus or species. There are also plasmids that have the capability of transferring to a particular host but cannot replicate in the new host or do not replicate well. In these circumstances the plasmid may be lost, however if it contains a resistance gene on a transposon this genetic element can translocate to the bacterial chromosome and be maintained in the absence of the plasmid. Therefore a plasmid does not necessarily need to be maintained in a particular host in order to contribute to the spread of resistance.

Both circular and linear plasmids have been described. Circular plasmids have in general been more intensively investigated then linear plasmids. This probably reflects the relative ease which they can be separated from the bacterial chromosome. Nonetheless linear plasmids have now been relatively well characterized and have been shown to convey advantageous phenotypes on the host. Like circular plasmids linear plasmids are often capable of conjugation (Meinhart et al., [@B104]; Chaconas and Kobryn, [@B30]).

Some (resistance) plasmid types cannot coexist in a microbial cell and this fact gave rise to the division into incompatibility groups (Couturier et al., [@B38]). Four major groups have been defined on the basis of genetic relatedness and pilus structure: IncF group (containing IncC, IncD, IncF, IncJ, and IncS), IncI group (including IncB, IncI, and IncK), IncP group (consisting of IncM, IncP, IncU, and IncW), and Ti.

Conjugative elements (integrative)
----------------------------------

The integrative conjugative elements (ICE), also called conjugative transposons (Roberts et al., [@B133]), like the conjugative plasmids contain an origin of transfer and the genes required to make the conjugation apparatus. Unlike plasmids these elements do not contain an origin of replication and have to integrate into a replicon in order to be maintained. This replicon can be either plasmid or chromosome. This gives them an advantage over plasmids as they do not have to have replication machinery that is compatible with the host so tend to have a larger host range than plasmids.

Integrative conjugative elements are a highly heterogeneous group of genetic elements with different properties and host ranges. However in general they do have a modular organization, i.e., a conjugation, recombination, regulation, and accessory modules. The latter commonly contains genes encoding AR.

There are also integrative elements that do not contain the conjugation region but can by mobilized by co-resident conjugative ICE or conjugative plasmids. Again these can mediate the spread of AR. There have been a number of comprehensive reviews in this area (Roberts and Mullany, [@B134]; Frost and Koraimann, [@B54]; Wozniak and Waldor, [@B178]).

Transduction
------------

There have been examples of AR genes, and even entire mobile genetic elements, being mobilized by transduction (Willi et al., [@B174]; Del Grosso et al., [@B42]). Transduction is a process in which the phage particles are packaged with bacterial DNA instead of phage. There are two type of transduction, generalized in which any segment of bacterial DNA can be packaged into the phage head, and specialized, in which the DNA adjacent to the phage insertion site is packaged.

Translocation within genomes
----------------------------

The simplest of the mobile genetic elements are insertion sequence (IS). These elements just consist of the gene required for element mobility and the inverted repeat at the ends of the element. IS elements can be as short as 1Kb (Siguier et al., [@B149]). When these elements contain accessory genes not involved in element translocation they are called transposons. A simple transposon will contain an accessory gene (often encoding AR) together with the transposase (for examples of each type of element see Roberts et al., [@B133]). There are more complex classes of transposons that move using different mechanisms including class II transposons.

The transposons mentioned above are not capable of conjugal transfer to other bacteria and in order for them to be disseminated they need to be contained within a conjugative element. However some of ICE elements as well as being able to transfer to new hosts (see above) are also able to transpose to new genomic sites. Their ability to use different integration sites in the chromosomes depends on the type of recombinases they contain. For example Tn*916* can use a large number of different integration sites in most hosts (reviewed in Roberts and Mullany, [@B134]). However some elements are highly site-specific such as Tn*916* (Wozniak and Waldor, [@B178]). Presumably elements like Tn*916* have evolved to use different integration sites in order to increase their host range. Elements that can only use a particular number of insertion sites are limited in the hosts they can use if the site is mutated or occupied.

Gene capture elements
---------------------

Integrons are genetic elements that include components of a site-specific recombination system enabling them to capture and mobilize genes, in particular AR determinants (Stokes and Hall, [@B157]; Rechia and Hall, [@B130]; Fluit and Schmitz, [@B53]; Depardieu et al., [@B43]). They harbor an *intI* gene, encoding a site-specific integrase of the tyrosine recombinase family that carries out recombination between two distinct target sites, i.e., an attI recombination site and a 59-base element (attC site) where attI is the target site for cassette integration and a promoter (Hall and Stokes, [@B61]; Hall and Collis, [@B60]; Rechia and Hall, [@B131]; Mazel, [@B99]). In contrast to transposons integrons are not flanked by repeat sequences, in addition they do not include any genes encoding proteins that catalyze their movement. HGT of integrons to other bacteria is mostly mediated by plasmids or transposons.

The *intI* genes have been used as a basis for grouping integrons into "classes." Currently, four classes are recognized; those carrying *intI1* are defined as class 1, *intI2* as class 2, *intI3* as class 3, and *intI4* as class 4 (Carattoli, [@B23]; Partridge et al., [@B118]).

Factors influencing acquisition of mobile genetic elements
----------------------------------------------------------

The ability of mobile genetic elements containing AR genes to spread is modulated by a range of factors including, selective pressures in the environment, host factors, and properties of the genetic elements themselves. Each of these factors will be examined in turn in the next sections.

### Specific host encoded factors

Bacteria have a number of systems that protect them from incoming DNA, including restriction/modification systems and CRISPR-Cas systems (Makarova et al., [@B93]). These systems although mechanistically very different have the same end point of identifying and destroying foreign DNA. Restriction systems work by identifying particular sequences in the incoming DNA that have not been protected by methylation and digesting them. CRISPRs act as a memory of past infection by a mobile element and can destroy that element if the bacterium encounters it again. Both these systems can be effective in stopping the spread of phage, ICE, and plasmids.

A specific host factor that attracts mobile elements has been documented in the pheromone responsive systems, in which a plasmid less recipient secrets a pheromone to which plasmids containing strains respond and transfer their plasmid to the recipients (Palmer et al., [@B114]).

### None specific host factors

Some none specific factors that can act as barriers to HGT have been eluded to above such as not having the target site for a particular ICE or having incompatible replication systems that stop plasmids replicating in a particular host. Also the architecture of the cell surface my not allow the conjugation systems of all mobile elements to work productively. Additionally one member of a mating pair may produce inhibitory substances. Bacteria produce a number of antimicrobial products the most common being the peptide antibiotics. The best understood are the colicins produced by *E. coli*. Gram-positive bacteria also produce a diverse array of antimicrobial peptides (Riley and Wertz, [@B132]).

### Genetic element encoded factors

Mobile genetic elements have a plethora of ways to overcome bacterial defense systems. Many plasmids and ICE encode anti-restriction proteins that as the name suggests inactivate the host restriction system allowing the element to enter the new host and survive. Also many mobile genetic elements do not have many restriction enzyme recognition sites so that they avoid the attention of the restriction enzymes. Some, including the common Tn*916*-like family of conjugative transposons, encode anti-restriction proteins which have been shown to mimic DNA and are recognized by the restriction enzyme. The anti-restriction protein ArdA from Tn*916* is one of the best characterized (McMahon et al., [@B103]).

Many transposons and ICE can transpose into essential genes. If this happens the host will die, to get around this some mobile elements are site-specific or preferentially target inter-genic regions (Cookson et al., [@B35]). Also most transposable elements (including ICE) are tightly regulated so that they only transpose at low frequency or transpose when the bacteria are stressed, such as antibiotics in their environment (reviewed in Roberts and Mullany, [@B134]; Wozniak and Waldor, [@B178]). For example members of the CTndot family of ICE transfer at a much higher frequency in the presence of tetracycline (the antibiotic to which they encode resistance). This is an advantageous response for both the element and the host bacteria (Moon et al., [@B105]).

### Environmental factors

All the factors outlined in the previous sections are important in modulating the spread of AR but obviously if antibiotics are present in the environment there is strong selective pressure for spread of resistance and those factors that promote the spread of resistance will be selected for and those stopping the spread of mobile elements selected against.

Gene transfer is also more likely in environments where bacteria are in close proximity to each other and in relatively high density such as the gut and oral cavity. In order to control the spread of resistance it is important to have an understanding of the molecular biology of the different mobile genetic elements and of the ecology of the environments in which spread is likely.
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